Heterocyclic compound and resistant harmful arthropod-controlling method for composition containing same

Abstract

The present invention provides a compound having outstanding effectiveness against resistant harmful arthropods, a composition containing the same, and a control method. A compound represented by formula (I) [in which R1 denotes a C1-C6 chain hydrocarbon group or the like, R2 denotes a C1-C6 chain hydrocarbon group or the like, R3 and R7 denote hydrogen atoms or the like, R4 and R6 denote hydrogen atoms or the like, R5 denotes a hydrogen atom or the like, Q denotes a group represented by formula Q1 or the like, ＃ denotes a binding site with a pyridine ring, ● denotes a binding site with a benzene ring, A1 denotes a nitrogen atom or the like, A2 denotes a nitrogen atom or the like, and A3 denotes a nitrogen atom or the like], or an N-oxide or a salt thereof has an outstanding controlling effect on resistant harmful arthropods.

Description

Heterocyclic compounds and compositions containing the same for controlling resistant arthropod pests

[0001] This patent application claims priority under the Paris Convention and the benefit of Japanese Patent Application No. 2021-107328 (filed June 29, 2021), the entire contents of which are incorporated herein by reference. The present invention relates to a method for controlling resistant arthropod pests using a heterocyclic compound and a composition containing the same. The present invention also relates to a heterocyclic compound and a composition containing the same for controlling resistant arthropod pests.

[0002] Various compounds have been investigated so far for the purpose of controlling harmful arthropods. For example, Patent Document 1 describes that certain compounds have a pest control effect.

[0003] JP 2002-114783 A

[0004] An object of the present invention is to provide an excellent method for controlling resistant arthropod pests. Another object of the present invention is to provide a compound having excellent control activity against resistant arthropod pests.

[0005] The present inventors have conducted research to find a method for controlling resistant arthropod pests that exhibits excellent control efficacy, and as a result, have found that a compound represented by the following formula (I) and a composition containing the compound exhibit excellent control efficacy against resistant arthropod pests. The present invention is as follows. [1] Formula (I) [In the formula, R 1 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more substituents selected from Group A), a C3-C7 cycloalkyl group optionally substituted with one or more substituents selected from Group B, a C3-C7 cycloalkenyl group, a phenyl group, a 3- to 7-membered non-aromatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group (the C3-C7 cycloalkenyl group, the phenyl group, the 3- to 7-membered non-aromatic heterocyclic group, and the 5- or 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group C), a nitro group, NR 8 R9 , S(O) m R 10 or a halogen atom, m represents 0, 1 or 2, R 2 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more substituents selected from Group A), a C3-C7 cycloalkyl group optionally substituted with one or more substituents selected from Group B, a C3-C7 cycloalkenyl group, a phenyl group, a 3- to 7-membered non-aromatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group (the C3-C7 cycloalkenyl group, the phenyl group, the 3- to 7-membered non-aromatic heterocyclic group, and the 5- or 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group C), a nitro group, NR 8a R 9a , S(O) n R 10a , a halogen atom, or a hydrogen atom; n represents 0, 1, or 2; R 3 and R 7 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 4 and R 6 are the same or different and represent a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C3-C6 cycloalkyl group, a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C3-C6 cycloalkyl group, the phenyl group, and the 5- or 6-membered aromatic heterocyclic group are optionally substituted with one or more halogen atoms}, a cyano group, a nitro group, a halogen atom, or a hydrogen atom, R 5represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group are optionally substituted with one or more halogen atoms}, a nitro group, a halogen atom, or a hydrogen atom, R 8 and R 8a are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom; R 9 and R 9a are the same or different and represent a C1-C6 chain hydrocarbon group, a C3-C7 cycloalkyl group, a C3-C7 cycloalkenyl group (the C1-C6 chain hydrocarbon group, the C3-C7 cycloalkyl group and the C3-C7 cycloalkenyl group may be substituted with one or more substituents selected from Group C), or a hydrogen atom; R 10 and R 10a are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, Q represents a group represented by formula Q1, a group represented by formula Q2, a group represented by formula Q3, or a group represented by formula Q4 (# represents the bonding site to the pyridine ring, and ● represents the bonding site to the benzene ring), A 1 is a nitrogen atom or CR 11 represents, 2 is an oxygen atom, a sulfur atom, or NR 12 represents, 3 is a nitrogen atom or CR 13 represents, 4 is a nitrogen atom or CR 14 represents, 5 is a nitrogen atom or CR 15 represents, 6 is a nitrogen atom or CR 16 represents R 11 , R 13, R 14 , R 15 and R 16 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 12 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom. Group A: a group consisting of a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C3-C6 cycloalkyl group (the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, and the C3-C6 cycloalkyl group are optionally substituted with one or more halogen atoms), a cyano group, and a halogen atom. and a group consisting of a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom. Group B: a group consisting of a C1-C6 open chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group (the C1-C6 open chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, and the C3-C6 alkynyloxy group are optionally substituted with one or more halogen atoms), a hydroxy group, a cyano group, a nitro group, and a halogen atom. Group C: a group consisting of a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom.] (hereinafter, the compound represented by formula (I) will be referred to as "the present compound N"), or an N-oxide or a salt thereof (hereinafter, the compound represented by formula (I) or the N-oxide or a salt thereof will be referred to as "the present compound"). [2] In the compound represented by formula (I), its N-oxide, or a salt thereof, Q is a group represented by formula Q1 or a group represented by formula Q4, 1 and A 3 is a nitrogen atom, 2 is an oxygen atom or NR 12 and R 1a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), a nitro group, S(O) m R 10 or a halogen atom, R 2 a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), a nitro group, S(O) n R 10a , a halogen atom, or a hydrogen atom. [3] The method according to either [1] or [2], wherein in the compound represented by formula (I), or the N-oxide thereof, or a salt thereof, Q is a group represented by formula Q1. [4] The method according to formula (I), or the N-oxide thereof, or a salt thereof, Q is a group represented by formula Q2 or a group represented by formula Q3, 4 is CR 14 and A 5 is a nitrogen atom or CR 15 and A 6 is a nitrogen atom, and R 1 a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), a nitro group, S(O) m R 10 or a halogen atom, R 2 a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), a nitro group, S(O) n R 10a, a halogen atom, or a hydrogen atom. [5] The method according to either [1] or [4], wherein in the compound represented by formula (I), its N-oxide, or a salt thereof, Q is a group represented by formula Q2. [6] The method according to either [1] or [4], wherein Q is a group represented by formula Q2. [In the formula, R 21 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), S(O) ｐ R 28 or a halogen atom, R 22 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), S(O) ｑ R 29 , a halogen atom, or a hydrogen atom; R 23 , R 25 and R 27 are the same or different and represent a fluorine atom or a hydrogen atom; R 24 represents a C1-C6 alkoxy group substituted with one or more halogen atoms or a fluorine atom, R 26 represents a halogen atom or a hydrogen atom; 28 and R 29 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, and p and q each independently represent 0, 1 or 2.] or an N-oxide or a salt thereof (hereinafter, the compound represented by formula (II) or an N-oxide or a salt thereof will be referred to as compound AA of the present invention). [7] R 21 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a halogen atom, and R 22 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, and R 23 , R 25and R 27 are the same or different and are a fluorine atom or a hydrogen atom, R 24 is a C1-C6 alkoxy group substituted with one or more halogen atoms, or a fluorine atom, and R 26 is a halogen atom or a hydrogen atom (hereinafter, the compound according to [7], the N-oxide thereof, or a salt thereof will be referred to as Compound A of the present invention). [8] A compound according to formula (II-a) [In the formula, R 21a is a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 alkoxy group and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), or S(O) ｒ R 28a represents R 22a represents a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 alkoxy group and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), S(O) ｓ R 29a or a halogen atom, R 23a , R 25a and R 27a are the same or different and represent a halogen atom or a hydrogen atom; R 24a represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group substituted with one or more halogen atoms, or a halogen atom; R 26a represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 28a and R 29a are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, and r and s each independently represent 0, 1 or 2.] or an N-oxide or a salt thereof (hereinafter, the compound represented by formula (II-a) or an N-oxide or a salt thereof will be referred to as compound A2 of the present invention). [9] A compound represented by formula (III) [In the formula, R 31 , R 32, R 33 , R 34 , R 35 , R 36 , and R 37 The combination of R 31 and R 32 is a chlorine atom, and R 33 , R 35 and R 37 is a hydrogen atom, and R 34 is a C1-C6 alkoxy group substituted with one or more halogen atoms, and R 36 is a halogen atom; or 31 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms or a bromine atom, R 32 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a bromine atom, or a hydrogen atom, and R 33 , R 35 and R 37 are the same or different and are a fluorine atom or a hydrogen atom, R 34 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, or a halogen atom, and R 36 represents a combination in which R is a halogen atom or a hydrogen atom; 38 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.], or an N-oxide thereof, or a salt thereof (hereinafter, the compound represented by formula (III), or an N-oxide thereof, or a salt thereof will be referred to as compound B of the present invention).

[10] A compound represented by formula (IV) [In the formula, R 41 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a halogen atom; R 42 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 43 , R 45 and R 47 are the same or different and represent a fluorine atom or a hydrogen atom; R 44represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R 46 represents a halogen atom or a hydrogen atom.] or an N-oxide thereof or a salt thereof (hereinafter, the compound represented by formula (IV), the N-oxide thereof or a salt thereof will be referred to as compound C of the present invention).

[11] A composition containing the compound according to any one of [6] to

[10] , the N-oxide thereof or a salt thereof, and an inert carrier.

[12] A composition containing one or more components selected from the group consisting of group (a), group (b), group (c) and group (d), and the compound according to any one of [6] to

[10] , the N-oxide thereof or a salt thereof: Group (a): a group consisting of insecticidal active ingredients, acaricidal active ingredients and nematicidal active ingredients; Group (b): a fungicidal active ingredient; Group (c): a plant growth regulator ingredient; Group (d): a repellent ingredient.

[13] A method for controlling resistant pests, comprising applying an effective amount of the compound according to any one of [6] to

[10] , or its N-oxide, or a salt thereof, or an effective amount of the composition according to

[12] to the resistant pests or to a habitat of the resistant pests.

[14] The method according to any one of [1] to [5] or

[13] , wherein the resistant pests are Hemiptera pests.

[15] The method according to any one of [1] to [5] or

[13] , wherein the resistant pests are Aphididae pests, Delphacidae pests, or Aleyrodidae pests.

[16] A seed or a vegetative reproductive organ carrying an effective amount of the compound according to any one of [6] to

[10] , or its N-oxide, or a salt thereof, or an effective amount of the composition according to

[12] .

[0006] According to the present invention, resistant arthropod pests can be controlled.

[0007] The substituents used in the present invention will be explained. A halogen atom refers to a fluorine atom, chlorine atom, bromine atom, or iodine atom. When a substituent is substituted with two or more halogen atoms or substituents, these halogen atoms or substituents may be the same or different. In this specification, the notation "CX-CY" means that the number of carbon atoms is X to Y. For example, the notation "C1-C6" means that the number of carbon atoms is 1 to 6. The chain hydrocarbon group represents an alkyl group, an alkenyl group, or an alkynyl group. Examples of alkyl groups include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a 1-ethylpropyl group, a butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, and a hexyl group. Examples of alkenyl groups include vinyl, 1-propenyl, 2-propenyl, 1-methyl-1-propenyl, 1-methyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1-ethyl-2-propenyl, 3-butenyl, 4-pentenyl, and 5-hexenyl. Examples of alkynyl groups include ethynyl, 1-propynyl, 2-propynyl, 1-methyl-2-propynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 2-butynyl, 4-pentynyl, and 5-hexynyl. Examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy, and hexyloxy. Examples of alkenyloxy groups include 2-propenyloxy groups, 2-butenyloxy groups, and 5-hexenyloxy groups. Examples of alkynyloxy groups include 2-propynyloxy groups, 2-butynyloxy groups, and 5-hexynyloxy groups. Examples of alkylsulfanyl groups include methylsulfanyl groups, ethylsulfanyl groups, isopropylsulfanyl groups, and hexylsulfanyl groups. Examples of alkylsulfinyl groups include methylsulfinyl groups, ethylsulfinyl groups, isopropylsulfinyl groups, and hexylsulfinyl groups.Examples of the alkylsulfonyl group include a methylsulfonyl group, an ethylsulfonyl group, an isopropylsulfonyl group, and a hexylsulfonyl group.

[0008] Examples of cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and cycloheptyl groups. Examples of cycloalkenyl groups include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, and cycloheptenyl groups.

[0009] Examples of the 3- to 7-membered non-aromatic heterocyclic group include an aziridinyl group, an oxiranyl group, a thiiranyl group, an azetidinyl group, an oxetanyl group, a thietanyl group, a pyrrolidinyl group, a tetrahydrofuranyl group, a tetrahydrothienyl group, a piperidyl group, a pyranyl group, a dihydropyranyl group, a tetrahydropyranyl group, a tetrahydrothiopyranyl group, an azepanyl group, an oxepanyl group, a thiepanyl group, a pyrazolinyl group, a pyrazolidinyl group, an imidazolinyl group, an imidazolidinyl group, an oxazolinyl group, a thiazolinyl group, an oxazolidinyl group, a thiazolidinyl group, an isoxazolinyl group, an isoxazolidinyl group, an isothiazolinyl group, an isothiazolidinyl group, a dioxolyl group, a dioxolanyl group, a dioxanyl group, a morpholinyl group, a thiomorpholinyl group, and a piperazinyl group. Examples of the 5- or 6-membered aromatic heterocyclic group include a pyrrolyl group, a furyl group, a thienyl group, a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, a thiadiazolyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, a pyrazinyl group, a triazinyl group, and a tetrazinyl group.

[0010] Examples of the N-oxide of the compound of formula (I) include the compounds of the following formula: [In the formula, the symbols have the same meanings as above.]

[0011] Compound AA, Compound A, Compound A2, Compound B, and Compound C of the present invention are hereinafter referred to as the compounds of the present invention. The present compounds (including the compounds of the present invention) may exist as one or more stereoisomers. Examples of stereoisomers include enantiomers, diastereomers, and geometric isomers. The present compounds include each stereoisomer and a mixture of stereoisomers in any ratio.

[0012] The compound represented by formula (I) or its N-oxide may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrogen chloride, phosphoric acid, and sulfuric acid, and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid. The acid addition salt can be obtained by mixing the compound represented by formula (I) or its N-oxide with an acid.

[0013] The following compounds are examples of the present compound N.

[0014] [Aspect 1] In the present compound N, R 1 a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), a nitro group, S(O) m R 10 or a halogen atom, R 2 a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), a nitro group, S(O) n R 10a , a halogen atom, or a hydrogen atom. 1 is a halogen atom, and R 2 is a halogen atom or a hydrogen atom. 1 and R 2is a chlorine atom. [Aspect 4] A compound of the present compound N, in which Q is a group represented by formula Q1 or a group represented by formula Q4. [Aspect 5] A compound of the present compound N, in which Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 6] In the compound N, Q is a group represented by the formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 7] In the compound N, Q is a group represented by the formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Embodiment 8] In the compound N, Q is a group represented by the formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 9] A compound in Aspect 1, wherein Q is a group represented by formula Q1 or a group represented by formula Q4. [Aspect 10] A compound in Aspect 2, wherein Q is a group represented by formula Q1 or a group represented by formula Q4. [Aspect 11] A compound in Aspect 3, wherein Q is a group represented by formula Q1 or a group represented by formula Q4. [Aspect 12] A compound in Aspect 1, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 13] A compound according to aspect 2, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 14] A compound according to aspect 3, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 15] A compound according to aspect 1, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 16] A compound according to aspect 2, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 17] A compound according to aspect 3, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 18] A compound according to aspect 1, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2is an oxygen atom. [Aspect 19] The compound according to aspect 2, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect 20] In aspect 3, Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect 21] A compound according to aspect 1, wherein Q is a group represented by the formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 22] A compound according to aspect 2, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 23] A compound according to aspect 3, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 NR 12 and R 12 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect 24] A compound according to any one of Aspects 1 to 23 or the present compound N, wherein R 3 and R 7 are the same or different and are a halogen atom or a hydrogen atom. [Aspect 25] In any of Aspects 1 to 23 or this compound N, R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C6 cycloalkyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom, and R 5is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a nitro group, a halogen atom, or a hydrogen atom. [Aspect 26] A compound in any of Aspects 1 to 23 or this compound N, wherein R 3 and R 7 are the same or different and are a halogen atom or a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C6 cycloalkyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom, and R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a nitro group, a halogen atom, or a hydrogen atom. [Aspect 27] A compound in any of Aspects 1 to 23 or this compound N, wherein R 3 and R 7 is a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C6 cycloalkyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom, and R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a nitro group, a halogen atom, or a hydrogen atom. [Aspect 28] A compound in any of Aspects 1 to 23 or this compound N, wherein R 4 , R 5 , and R 6are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect 29] A compound in any of Aspects 1 to 23 or this compound N, wherein R 3 and R 7 are the same or different and are a halogen atom or a hydrogen atom, and R 4 , R 5 , and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect 30] A compound in any of Aspects 1 to 23 or this compound N, wherein R 3 and R 7 is a hydrogen atom, and R 4 , R 5 , and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect 31] A compound in any of Aspects 1 to 23 or this compound N, wherein R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 5 is a halogen atom or a hydrogen atom. [Aspect 32] In any of Aspects 1 to 23 or the present compound N, R 3 and R 7 are the same or different and are a halogen atom or a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 5 is a halogen atom or a hydrogen atom. [Embodiment 33] In any of Embodiments 1 to 23 or the present compound N, R 3 and R 7is a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 5 is a halogen atom or a hydrogen atom. [Embodiment 34] In any one of Embodiments 1 to 23 or the present compound N, R 4 and R 6 are the same or different and are C1-C6 alkoxy groups optionally substituted with one or more halogen atoms, and R 5 is a halogen atom or a hydrogen atom. [Embodiment 35] In any one of Embodiments 1 to 23 or the present compound N, R 3 and R 7 are the same or different and are a halogen atom or a hydrogen atom, and R 4 and R 6 are the same or different and are C1-C6 alkoxy groups optionally substituted with one or more halogen atoms, and R 5 is a halogen atom or a hydrogen atom. [Aspect 36] In any of Aspects 1 to 23 or the present compound N, R 3 and R 7 is a hydrogen atom, and R 4 and R 6 are the same or different and are C1-C6 alkoxy groups optionally substituted with one or more halogen atoms, and R 5 is a halogen atom or a hydrogen atom. [Embodiment 37] In any of Embodiments 1 to 23 or the present compound N, R 4 , R 5 , and R 6 are the same or different and are a halogen atom or a hydrogen atom. [Aspect 38] In any of Aspects 1 to 23 or the present compound N, R 3 and R 7 are the same or different and are a halogen atom or a hydrogen atom, and R 4 , R 5 , and R 6 are the same or different and are a halogen atom or a hydrogen atom. [Aspect 39] In any of Aspects 1 to 23 or the present compound N, R 3 and R 7 is a hydrogen atom, and R4 , R 5 , and R 6 are the same or different and are halogen atoms or hydrogen atoms.

[0015] [Aspect N1] In the compound N, R 1 a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), S(O) m R 10 or a halogen atom, R 2 is a C1-C6 alkoxy group, a C3-C7 cycloalkyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms), S(O) n R 10a , a halogen atom, or a hydrogen atom. [Aspect N2] In this compound N, R 1 is a C1-C4 alkoxy group, a cyclopropyl group (the C1-C4 alkoxy group and the cyclopropyl group may be substituted with one or more halogen atoms), S(O) m R 10 or a halogen atom, R 2 is a halogen atom or a hydrogen atom, and R １０ is a C1-C4 chain hydrocarbon group optionally substituted with one or more halogen atoms. [Aspect N3] In this compound N, R 1 is a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group (the C1-C4 alkoxy group and the C1-C4 alkylsulfanyl group may be substituted with one or more halogen atoms), or a halogen atom, and R 2 is a halogen atom or a hydrogen atom. [Aspect N4] In this compound N, R 1 is a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group (the C1-C4 alkoxy group and the C1-C4 alkylsulfanyl group may be substituted with one or more halogen atoms), or a halogen atom, and R 2is a chlorine atom or a hydrogen atom. [Aspect N5] In this compound N, R 1 is a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group, or a chlorine atom, and R 2 is a chlorine atom or a hydrogen atom. [Aspect N6] In this compound N, R 1 is a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group, or a chlorine atom, and R 2 is a chlorine atom. [Aspect N7] In this compound N, R 1 is a C1-C4 alkoxy group or a chlorine atom, and R 2 is a chlorine atom. [Aspect N8] In this compound N, Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms. [Aspect N9] In this compound N, Q is a group represented by the formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms. [Aspect N10] A compound in aspect N1, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N11] A compound in aspect N2, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N12] A compound in aspect N3, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N13] A compound in aspect N4, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N14] In aspect N5, Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N15] A compound in aspect N6, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N16] A compound in aspect N7, wherein Q is a group represented by formula Q1 or a group represented by formula Q4, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N17] The compound according to aspect N1, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N18] The compound in aspect N2, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N19] The compound in aspect N3, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N20] A compound according to aspect N4, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N21] A compound according to aspect N5, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N22] A compound in aspect N6, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N23] The compound according to aspect N7, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2is an oxygen atom or NR 12 and R 12 is a methyl group optionally substituted with one or more halogen atoms or a hydrogen atom. [Aspect N24] The compound in aspect N1, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect N25] A compound in aspect N2, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect N26] The compound according to aspect N3, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect N27] The compound according to aspect N4, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect N28] The compound according to aspect N5, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect N29] The compound according to aspect N6, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 is an oxygen atom. [Aspect N30] A compound according to aspect N7, wherein Q is a group represented by formula Q1, and A 1 and A 3 is a nitrogen atom, and A 2 [Aspect N31] In any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, R 3 and R 7 are the same or different and are a methyl group, a halogen atom, or a hydrogen atom. [Aspect N32] In any of Aspects 1 to 23, Aspects N1 to N30, or this compound N, R 3 is a methyl group, a chlorine atom, or a hydrogen atom, and R 7is a hydrogen atom. [Aspect N33] In any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, R 3 and R 7 [Aspect N34] In any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom. [Aspect N35] A compound in any of Aspects 1 to 23, Aspects N1 to N30, or this Compound N, wherein R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a nitro group, a halogen atom, or a hydrogen atom. [Aspect N36] A compound in any of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom; R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect N37] A compound in any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 4 and R 6are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group (the C1-C4 alkyl group, the C1-C4 alkoxy group, and the C1-C4 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom; R 5 is a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect N38] A compound in any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 3 is a methyl group, a chlorine atom, or a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom; R 7 [Aspect N39] In any one of Aspects 1 to 23, Aspect N1 to Aspect N30, or this compound N, R 3 is a methyl group, a chlorine atom, or a hydrogen atom, and R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a nitro group, a halogen atom, or a hydrogen atom, and R 7 [Aspect N40] In any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, R 3 is a methyl group, a chlorine atom, or a hydrogen atom, and R 4 and R 6are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom; R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom, and R 7 [Aspect N41] In any one of Aspects 1 to 23, Aspect N1 to Aspect N30, or this compound N, R 3 is a methyl group, a chlorine atom, or a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group (the C1-C4 alkyl group, the C1-C4 alkoxy group, and the C1-C4 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom; R 5 is a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom, and R 7 [Aspect N42] In any one of Aspects 1 to 23, Aspect N1 to Aspect N30, or this compound N, R 3 and R 7 is a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom. [Aspect N43] A compound in any of Aspects 1 to 23, Aspects N1 to N30, or this Compound N, wherein R 3and R 7 is a hydrogen atom, and R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a nitro group, a halogen atom, or a hydrogen atom. [Aspect N44] A compound in any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 3 and R 7 is a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C1-C6 alkylsulfanyl group (the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom; R 5 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group (the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect N45] A compound in any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 3 and R 7 is a hydrogen atom, and R 4 and R 6 are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group (the C1-C4 alkyl group, the C1-C4 alkoxy group, and the C1-C4 alkylsulfanyl group may be substituted with one or more halogen atoms), a cyano group, a nitro group, a halogen atom, or a hydrogen atom; R 5 is a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect N46] A compound in any one of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 4 , R 5 , and R 6are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect N47] A compound in any of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 3 is a methyl group, a chlorine atom, or a hydrogen atom, and R 4 , R 5 , and R 6 are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom; R 7 [Aspect N48] In any one of Aspects 1 to 23, Aspect N1 to Aspect N30, or this compound N, R 3 and R 7 is a hydrogen atom, and R 4 , R 5 , and R 6 are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect N49] A compound in any of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 3 and R 7 is a hydrogen atom, and R 4 , R 5 , and R 6 are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom. [Aspect N50] A compound in any of Aspects 1 to 23, Aspects N1 to N30, or this compound N, wherein R 3 and R 7 is a hydrogen atom, and R 4 and R 5are the same or different and are a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom; R 6 [Aspect N51] In any one of Aspects 1 to 23, Aspect N1 to Aspect N30, or this compound N, R 3 and R 7 is a hydrogen atom, and R 4 is a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), a halogen atom, or a hydrogen atom, and R 5 is a halogen atom or a hydrogen atom, and R 6 A compound in which is a hydrogen atom.

[0016] The following compounds are examples of the compound AA of the present invention: [Aspect AA1] In the compound AA of the present invention, R ２１ is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, S(O) ｎ R ２８ or a halogen atom, R ２２ is a chlorine atom or a hydrogen atom, and R ２８ is a C1-C6 chain hydrocarbon group. [Aspect AA2] In the compound AA of the present invention, R ２１ is a C1-C4 alkyl group, a C1-C4 alkoxy group, a C1-C4 alkylsulfanyl group, or a chlorine atom, and R ２２ is a chlorine atom or a hydrogen atom. [Aspect AA3] In the compound AA of the present invention, R ２３ and R ２７ is a hydrogen atom. [Aspect AA4] A compound in aspect AA1, wherein R ２３ and R ２７ is a hydrogen atom. [Aspect AA5] A compound in aspect AA2, wherein R ２３ and R ２７ is a hydrogen atom. [Aspect AA6] In any of Aspects AA1 to AA5 or the compound AA of the present invention, R ２４ is a C1-C4 alkoxy group substituted with one or more halogen atoms or a fluorine atom, and R２５ is a fluorine atom or a hydrogen atom. [Aspect AA7] In any of Aspects AA1 to AA5 or the compound AA of the present invention, R ２４ is a C1-C4 alkoxy group substituted with one or more fluorine atoms or a fluorine atom, and R ２５ is a fluorine atom or a hydrogen atom. [Aspect AA8] In any of Aspects AA1 to AA5 or the compound AA of the present invention, R ２４ is a C1-C2 alkoxy group substituted with one or more fluorine atoms or a fluorine atom, and R ２５ is a fluorine atom or a hydrogen atom. [Aspect AA9] In any of Aspects AA1 to AA5 or the compound AA of the present invention, R ２４ is a methoxy group substituted with one or more fluorine atoms or a fluorine atom, and R ２５ is a fluorine atom or a hydrogen atom. [Aspect AA10] In any of Aspects AA1 to AA5 or the compound AA of the present invention, R ２４ is a methoxy group substituted with one or more fluorine atoms or a fluorine atom, and R ２５ A compound in which is a hydrogen atom.

[0017] The following compounds are examples of the compound A2 of the present invention. [Aspect A2-1] In the compound A2 of the present invention, R ２１ａ is a C1-C4 alkoxy group or a C1-C4 alkylsulfanyl group, and R ２２ａ is a chlorine atom, and R ２３ａ and R ２７ａ is a hydrogen atom, and R ２４ａ is a C1-C4 alkyl group, a C1-C4 alkoxy group (the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted with one or more halogen atoms), or a halogen atom, and R ２５ａ is a fluorine atom or a hydrogen atom.

[0018] The following compounds are examples of the compound B of the present invention: [Aspect B1] In the compound B of the present invention, R ３１ and R ３２ is a chlorine atom, and R ３３ , R ３５ and R ３７is a hydrogen atom, and R ３４ is a C1-C4 alkoxy group substituted with one or more halogen atoms, and R ３６ is a halogen atom, and R ３８ is a methyl group or a hydrogen atom. [Aspect B2] In compound B of the present invention, R ３１ and R ３２ is a chlorine atom, and R ３３ , R ３５ and R ３７ is a hydrogen atom, and R ３４ is a C1-C4 alkoxy group substituted with one or more fluorine atoms, and R ３６ is a fluorine atom, and R ３８ is a methyl group or a hydrogen atom.

[0019] The following compounds are examples of the compound C of the present invention: [Aspect C1] In the compound C of the present invention, R ４１ and R ４２ is a chlorine atom, and R ４３ and R ４７ is a hydrogen atom. [Aspect C2] A compound in aspect C1, ４４ is a halogen atom or a hydrogen atom, and R ４５ is a fluorine atom or a hydrogen atom, and R ４６ is a halogen atom or a hydrogen atom, and R ４３ and R ４７ A compound in which is a hydrogen atom.

[0020] Next, the method for producing the present compound (including the compound of the present invention) will be described.

[0021] Production Method 1 A compound represented by formula (I-1) (hereinafter referred to as compound (I-1)) can be produced by reacting a compound represented by formula (M-1) (hereinafter referred to as compound (M-1)) with a compound represented by formula (M-2) (hereinafter referred to as compound (M-2)) in the presence of a base and a catalyst. [wherein Q5 represents a group represented by formula Q1, a group represented by formula Q3, or a group represented by formula Q4; X 1represents a chlorine atom, a bromine atom, or an iodine atom, and other symbols have the same meanings as above.] The reaction is carried out in a solvent or in the absence of a solvent. Examples of the solvent include ethers (hereinafter referred to as ethers) such as tetrahydrofuran (hereinafter referred to as THF), 1,4-dioxane, 1,2-dimethoxyethane (hereinafter referred to as DME), methyl tert-butyl ether (hereinafter referred to as MTBE), and diethyl ether; halogenated hydrocarbons (hereinafter referred to as halogenated hydrocarbons) such as dichloromethane and chloroform; hydrocarbons (hereinafter referred to as hydrocarbons) such as hexane, toluene, and xylene; aprotic polar solvents (hereinafter referred to as aprotic polar solvents) such as N,N-dimethylformamide (hereinafter referred to as DMF), N-methylpyrrolidone, and dimethyl sulfoxide (hereinafter referred to as DMSO); nitriles (hereinafter referred to as nitriles) such as acetonitrile; water; and mixtures thereof. Examples of the base used in the reaction include organic bases such as triethylamine, diisopropylethylamine, pyridine, and 4-(dimethylamino)pyridine (hereinafter referred to as organic bases); alkali metal carbonates such as sodium carbonate and potassium carbonate (hereinafter referred to as alkali metal carbonates); alkali metal hydroxides such as sodium hydroxide and potassium hydroxide (hereinafter referred to as alkali metal hydroxides); alkali metal fluorides such as sodium fluoride, potassium fluoride, and cesium fluoride; and alkali metal phosphates such as tripotassium phosphate (hereinafter referred to as alkali metal phosphates). Examples of the catalyst used in the reaction include palladium(II) acetate, dichlorobis(triphenylphosphine)palladium(II), and bis(diphenylphosphineferrocenyl)palladium(II) dichloride. In the reaction, compound (M-2) is typically used in a ratio of 1 to 10 moles, a base is typically used in a ratio of 1 to 10 moles, and a catalyst is typically used in a ratio of 0.0001 to 1 mole, relative to 1 mole of compound (M-1). A ligand may be used in the reaction, if necessary.Examples of the ligand include triphenylphosphine, 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (hereinafter referred to as Xantphos), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, 2,2'-bipyridine, 2-aminoethanol, 8-hydroxyquinoline, 1,10-phenanthroline, trans-1,2-cyclohexanediamine, trans-N,N'-dimethylcyclohexane-1,2-diamine, and N,N'-dimethylethylenediamine. When a ligand is used in the reaction, the ligand is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (M-1). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.1 to 24 hours. After completion of the reaction, compound (I-1) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer. Compound (M-2) is a commercially available compound or can be produced according to known methods.

[0022] Production Method 2 A compound represented by formula (I-2) (hereinafter referred to as compound (I-2)) can be produced by reacting a compound represented by formula (M-3) (hereinafter referred to as compound (M-3)) with a compound represented by formula (M-4) (hereinafter referred to as compound (M-4)) in the presence of a base. [In the formula, X 2represents a fluorine atom or a chlorine atom, and other symbols have the same meanings as above.] The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkali metal hydroxides, and alkali metal phosphates. In the reaction, compound (M-4) is usually used in a ratio of 1 to 10 moles, and a base is usually used in a ratio of 1 to 10 moles, relative to 1 mole of compound (M-3). In the reaction, a metal catalyst may be used, if necessary. Examples of the metal catalyst include copper catalysts such as copper(I) iodide, copper(I) bromide, copper(I) chloride, copper(I) oxide, copper(I) trifluoromethanesulfonate benzene complex, tetrakis(acetonitrile)copper(I) hexafluorophosphate, and copper(I) 2-thiophenecarboxylate; nickel catalysts such as bis(cyclooctadiene)nickel(0) and nickel(II) chloride; and palladium catalysts such as palladium(II) acetate, tetrakis(triphenylphosphine)palladium(0), and tris(dibenzylideneacetone)dipalladium(II). When a metal catalyst is used in the reaction, the metal catalyst is typically used in a ratio of 0.01 to 0.5 moles per mole of compound (M-3). A ligand may also be used in the reaction, if necessary. Examples of the ligand include triphenylphosphine, 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (hereinafter referred to as Xantphos), 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, 2,2'-bipyridine, 2-aminoethanol, 8-hydroxyquinoline, 1,10-phenanthroline, trans-1,2-cyclohexanediamine, trans-N,N'-dimethylcyclohexane-1,2-diamine, and N,N'-dimethylethylenediamine.When a ligand is used in the reaction, the ligand is typically used in a ratio of 0.01 to 0.5 moles per mole of compound (M-3). The reaction temperature is typically in the range of 0°C to 150°C. The reaction time is typically in the range of 0.5 to 24 hours. After completion of the reaction, compound (I-2) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatments such as drying and concentrating the organic layer. Compounds (M-3) and (M-4) are commercially available compounds or can be produced according to known methods.

[0023] Production Method 3 A compound represented by formula (I-3) (hereinafter referred to as compound (I-3)) can be produced by reacting a compound represented by formula (M-5) (hereinafter referred to as compound (M-5)) with a compound represented by formula (M-6) (hereinafter referred to as compound (M-6)) in the presence of a base. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkali metal hydroxides, and alkali metal phosphates. In the reaction, compound (M-6) is usually used in a ratio of 1 to 10 moles and the base is usually used in a ratio of 1 to 10 moles per mole of compound (M-5). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After completion of the reaction, compound (I-3) can be obtained by post-treatment such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer. Compound (M-6) is either a commercially available compound or can be produced according to known methods.

[0024] Production Method 4 A compound represented by formula (I-4) (hereinafter referred to as compound (I-4)) can be produced by reacting a compound represented by formula (M-7) (hereinafter referred to as compound (M-7)) in the presence of an acid. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the acid used in the reaction include paratoluenesulfonyl chloride. In the reaction, the acid is usually used in a ratio of 0.1 to 10 moles per mole of compound (M-7). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After completion of the reaction, compound (I-4) can be obtained by post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, and drying and concentrating the organic layer.

[0025] Production Method 5 A compound represented by formula (I-5) (hereinafter referred to as compound (I-5)) can be produced by reacting a compound represented by formula (M-8) (hereinafter referred to as compound (M-8)) with a compound represented by formula (M-9) (hereinafter referred to as compound (M-9)) in the presence of a base. [In the formula, the symbols have the same meanings as defined above.] The reaction can be carried out in accordance with Production Method 3, using compound (M-9) instead of compound (M-5) and compound (M-8) instead of compound (M-6). Compound (M-8) is a commercially available compound, or can be produced in accordance with known methods.

[0026] Production Method 6 The compound represented by formula (I-6) (hereinafter referred to as compound (I-6)) can be produced by reacting a compound represented by formula (M-10) (hereinafter referred to as compound (M-10)) with hydrazine. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Hydrazine may also be used in the form of hydrazine monohydrate or a hydrazine acid addition salt such as hydrazine hydrochloride or hydrazine sulfate. The reaction is usually carried out in a ratio of 0.5 to 10 moles per mole of compound (M-10). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After completion of the reaction, compound (I-6) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment such as drying and concentrating the organic layer. Compound (M-10) can be produced in accordance with the method described in WO 2012 / 098416.

[0027] Production Method 7 The compound represented by formula (I-7) (hereinafter referred to as compound (I-7)) can be produced by reacting compound (I-6) with a compound represented by formula (M-11) (hereinafter referred to as compound (M-11)) in the presence of a base. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkali metal hydroxides, and alkali metal phosphates. In the reaction, compound (M-11) is usually used in a ratio of 0.5 to 10 moles and the base is usually used in a ratio of 0.5 to 10 moles per mole of compound (I-6). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After completion of the reaction, compound (I-7) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment such as drying and concentrating the organic layer. Compound (M-11) is a commercially available compound or can be produced according to known methods.

[0028] The N-oxide of the compound of formula (I) can be produced by reacting the compound of formula (I) with an oxidizing agent. The reaction can be carried out, for example, according to the method described in U.S. Patent Application Publication No. 2018 / 0009778 or WO 2016 / 121970.

[0029] Reference Production Method 1 Compound (M-5) can be produced by reacting a compound represented by formula (M-5S) (hereinafter referred to as compound (M-5S)) with hydroxylamine. [In the formula, the symbols have the same meanings as defined above.] The reaction is usually carried out in a solvent. Examples of the solvent include alcohols such as methanol and ethanol (hereinafter referred to as alcohols); ethers; halogenated hydrocarbons; hydrocarbons; aprotic polar solvents; nitriles, and mixtures thereof. Hydroxylamine acid addition salts such as hydrochloride and sulfate can also be used. Hydroxylamine is usually used in a ratio of 0.5 to 10 moles per mole of compound (M-5S). An acid may be used in the reaction, if necessary. Examples of the acid include inorganic acids such as hydrogen chloride, phosphoric acid, and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid. When an acid is used in the reaction, the acid is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (M-5S). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is complete, compound (M-5) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatment operations such as drying and concentrating the organic layer. Compound (M-5S) is a commercially available compound or can be produced according to known methods.

[0030] Reference Production Method 2 Compound (M-9) can be produced by reacting a compound represented by formula (M-9S) (hereinafter referred to as compound (M-9S)) with hydroxylamine. [In the formula, the symbols have the same meanings as defined above.] The reaction can be carried out using compound (M-9S) instead of compound (M-5S) in accordance with Reference Production Method 1. Compound (M-9S) is a commercially available compound, or can be produced in accordance with known methods.

[0031] Reference Production Method 3 Compound (M-7) can be produced by reacting compound (M-8) with a compound represented by formula (M-7S) (hereinafter referred to as compound (M-7S)) in the presence of a base. The reaction is carried out in a solvent or in the absence of a solvent. Examples of suitable solvents include ethers, halogenated hydrocarbons, hydrocarbons, nitriles, nitrogen-containing aromatic compounds, aprotic polar solvents, and mixtures thereof. Examples of suitable bases include organic bases; alkali metal carbonates; and alkali metal hydrides such as sodium hydride and potassium hydride. For the reaction, compound (M-7S) is typically used in a ratio of 0.5 to 1.5 moles and base in a ratio of 1 to 3 moles per mole of compound (M-8). The reaction temperature is typically within the range of −20°C to 150°C. The reaction time is typically within the range of 0.5 to 24 hours. After completion of the reaction, compound (M-7) can be obtained by adding water to the reaction mixture, extracting with an organic solvent, and performing post-treatments such as drying and concentrating the organic layer. Compound (M-7S) is either a commercially available compound or can be prepared using known methods.

[0032] The compound of the present invention can be mixed or used in combination with one or more components selected from the group consisting of Group (a), Group (b), Group (c), and Group (d) below (hereinafter referred to as the present component). The term "mixed or used in combination" means that the compound of the present invention and the present component are used simultaneously, separately, or with a time interval. When the compound of the present invention and the present component are used simultaneously, the compound of the present invention and the present component may be contained in separate preparations or in a single preparation. One aspect of the present invention is a composition (hereinafter referred to as Composition A) containing one or more components selected from the group consisting of Group (a), Group (b), Group (c), and Group (d) (i.e., the present component) and the compound of the present invention.

[0033] Group (a) includes acetylcholinesterase inhibitors (e.g., carbamate insecticides, organophosphate insecticides), GABAergic chloride channel blockers (e.g., phenylpyrazole insecticides), sodium channel modulators (e.g., pyrethroid insecticides), nicotinic acetylcholine receptor competitive modulators (e.g., neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamate-gated chloride channel allosteric modulators (e.g., macrolide insecticides), juvenile hormone mimics, multisite inhibitors, chordotonal organ TRPV channel modulators, mite growth inhibitors, microbial insect midgut membrane disruptors, mitochondrial ATP synthase inhibitors, oxidative phosphorylation uncouplers, nicotinic acetylcholine receptor channel blockers (e.g., nereistoxin insecticides), chitin biosynthesis inhibitors, molting inhibitors, ecdysone receptor agonists, octopamine receptor agonists, mitochondrial electron transport chain complexes I and II, The group consisting of inhibitors of classes III and IV, voltage-dependent sodium channel blockers, acetyl-CoA carboxylase inhibitors, ryanodine receptor modulators (e.g., diamide insecticides), chordotonal organ modulators, microbial insecticides, and other insecticidal, acaricidal, and nematicidal active ingredients, which are described in the IRAC mechanism-based classification.

[0034] Group (b) consists of nucleic acid synthesis inhibitors (e.g., phenylamide fungicides, acylamino acid fungicides), cell division and cytoskeleton inhibitors (e.g., MBC fungicides), respiratory inhibitors (e.g., QoI fungicides, QiI fungicides), amino acid synthesis and protein synthesis inhibitors (e.g., anilinopyridine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (e.g., DMI fungicides such as triazoles), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, multisite contact-active fungicides, microbial fungicides, and other fungicidal active ingredients. These are listed in the FRAC classification based on the mechanism of action.

[0035] Group (c) is a group of plant growth regulators (including mycorrhizal fungi and rhizobia).

[0036] Group (d) is a group of repellent ingredients.

[0037] Examples of combinations of the present ingredient and the compound of the present invention are described below. For example, alanycarb + SX refers to a combination of alanycarb and SX. The abbreviation SX refers to any one of the present compounds selected from the compound group SX1 to SX1397. The present ingredients described below are all known ingredients and can be obtained from commercially available preparations or produced by known methods. When the present ingredient is a microorganism, it can also be obtained from a bacterial depository. The number in parentheses indicates the CAS RN (registered trademark).

[0038] Combinations of the present ingredient of the above group (a) with the compound of the present invention: abamectin + SX, acephate + SX, acequinocyl + SX, acetamiprid + SX, acetoprole + SX, acrinathrin + SX, acinonapyr + SX, afidopyropen + SX, afoxolaner + SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha-cypermethrin + SX, alpha-endosulfan + SX, aluminum phosphide + SX, Amitraz + SX, azadirachtin + SX, azamethiphos + SX, azinphos-ethyl + SX, azinphos-methyl + SX, azocyclotin + SX, Celastrus angulatus bark + SX, bendiocarb + SX, benfluthrin + SX, benfuracarb + SX, bensultap + SX, benzoximate + SX, benzpyrimoxan + SX, beta-cyfluthrin + SX, beta-cypermethrin + SX, bifenazate + SX, bifenthrin + SX, bioallethrin + SX,Bioresmethrin + SX, bistrifluron + SX, borax + SX, boric acid + SX, broflanilide + SX, bromopropylate + SX, buprofezin + SX, butocarboxim + SX, butoxycarboxim + SX, cadusafos + SX, calcium phosphide + SX, carbaryl + SX, carbofuran + SX, carbosulfan + SX, cartap hydrochloride + SX, cartap + SX Chinomethionate + SX, chlorantraniliprole + SX, chlordane + SX, chlorethoxyfos + SX, chlorfenapyr + SX, chlorfenvinphos + SX, chlorfluazuron + SX, chlormephos + SX, chloropicrin + SX, chlorpyrifos + SX, chlorpyrifos-methyl + SX, chromafenozide + SX, clofentezine + SX, clothianidin + SX, concanamycin A A) + SX, coumaphos + SX, cryolite + SX, cyanophos + SX, cyantraniliprole + SX,Cyclaniliprole + SX, cyclobutrifluram + SX, cycloprothrin + SX, cycloxaprid + SX, cyenopyrafen + SX, cyetpyrafen + SX, cyflumetofen + SX, cyfluthrin + SX, cyhalodiamide + SX, cyhalothrin + SX, cyhexatin + SX, cypermethrin + SX, cyphenothrin + SX, cyproflanilide + SX, cyromazine + SX, Dazomet + SX, deltamethrin + SX, demeton-S-methyl + SX, diafenthiuron + SX, diazinon + SX, dichlorvos + SX, dichloromezotiaz + SX, dicofol + SX, dicrotophos + SX, diflovidazin + SX, diflubenzuron + SX, dimefluthrin + SX, dimethoate + SX, dimethylvinphos + SX, dimpropyridaz + SX, Dinotefuran + SX, disodium octaborate + SX, disulfoton + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, doramectin + SX,Dried leaves of Dryopteris filix (mas) + SX, emamectin benzoate + SX, empenthrin + SX, endosulfan + SX, EPN (O-ethyl O-(4-nitrophenyl) phenylphosphonothioate) + SX, epsilon-metofluthrin + SX, epsilon-momfluorothrin + SX, esfenvalerate + SX, ethifencarb + SX, ethion + SX, ethiprole + SX, ethoprophos + SX, etofenprox + SX. Etoxazole + SX, Artemisia absinthium extract + SX, Azadirachta indica extract + SX, Cassia nigricans extract + SX, Clitoria ternatea extract + SX, Symphytum officinale extract + SX, Chenopodium ambrosioides extract (extracts or simulated blend of Chenopodium ambrosioides) + SX, Tansy extract + SX, Urtica dioica extract + SX, Viscum album extract + SX, Famphur + SX, Fenamiphos + SX, fenazaquin + SX,Fenbutatin oxide + SX, fenitrothion + SX, fenmezoditiaz + SX, fenobucarb + SX, fenoxycarb + SX, fenpropathrin + SX, fenpyroximate + SX, fenthion + SX, fenvalerate + SX, fipronil + SX, flometoquin + SX, flonicamid + SX, fluacrypyrim + SX, fluazaindolizine + SX, fluazuron + SX, Flubendiamide + SX, fluchlordiniliprole + SX, flucycloxuron + SX, flucythrinate + SX, fluensulfone + SX, flufenprox + SX, flufenoxuron + SX, flufiprole + SX, flumethrin + SX, flupentiofenox + SX, flupyradifurone + SX, flupyrimin + SX, fluralaner + SX, fluvalinate + SX, fluxametamide + SX, formetanate + SX, fosthiazate + SX, furamethrin + SX, furathiocarb + SX,Gamma-cyhalothrin + SX, GS-omega / kappa HXTX-Hv1a peptide + SX, halfenprox + SX, halofenozide + SX, heptafluthrin + SX, heptenophos + SX, hexaflumuron + SX, hexythiazox + SX, potassium salt of hop beta acid + SX, hydramethylnon + SX, hydroprene + SX, imicyafos + SX, imidacloprid + SX SX, imidaclothiz + SX, imiprothrin + SX, indazapyroxamet + SX, indoxacarb + SX, isocycloseram + SX, isofenphos + SX, isoprocarb + SX, isopropyl-O-(methoxyaminothiophosphoryl) salicylate + SX, isoxathion + SX, ivermectin + SX, kadethrin + SX, kappa-tefluthrin + SX, kappa-bifenthrin + SX Kinoprene + SX, lambda-cyhalothrin + SX, lenoremycin + SX, lepimectin + SX, lime sulfur + SX,Lotilaner + SX, lufenuron + SX, machine oil + SX, malathion + SX, mecarbam + SX, meperfluthrin + SX, metaflumizone + SX, metam + SX, methamidophos + SX, methidathion + SX, methiocarb + SX, methomyl + SX, methoprene + SX, methoxychlor + SX, methoxyfenozide + SX, methyl bromide + SX, metofluthrin + SX, Metolcarb + SX, metoxadiazone + SX, mevinphos + SX, milbemectin + SX, milbemycin oxime + SX, momfluorothrin + SX, monocrotophos + SX, moxidectin + SX, naled + SX, nicofluprole + SX, nicotine + SX, nicotine sulfate + SX, nitenpyram + SX, novaluron + SX, noviflumuron + SX, Chenopodium oil anthelminticum + SX, omethoate + SX, oxamyl + SX, oxazosulfyl + SX,Oxydemeton-methyl + SX, parathion + SX, parathion-methyl + SX, permethrin + SX, phenothrin + SX, phenthoate + SX, phorate + SX, phosalone + SX, phosmet + SX, phosphamidon + SX, phosphine + SX, phoxim + SX, pirimicarb + SX, pirimiphos-methyl + SX, prallethrin + SX, profenofos + SX, profluthrin + SX, Propargite + SX, propetamphos + SX, propoxur + SX, propylene glycol alginate + SX, prothiofos + SX, pyflubumide + SX, pymetrozine + SX, pyraclofos + SX, pyrethrins + SX, pyridaben + SX, pyridalyl + SX, pyridaphenthion + SX, pyrifluquinazone + SX, pyrimidifen + SX, pyriminostrobin + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, rotenone + SX,Ryanodine + SX, sarolaner + SX, selamectin + SX, sigma-cypermethrin + SX, silafluofen + SX, sodium borate + SX, sodium metaborate + SX, spidoxamat + SX, spinetoram + SX, spinosad + SX, spirobudifen + SX, spirodiclofen + SX, spiromesifen + SX, spiropidione + SX, spirotetramat + SX, Sulfluramid + SX, sulfotep + SX, sulfoxaflor + SX, sulfur + SX, sulfuryl fluoride + SX, tartar emetic + SX, tau-fluvalinate + SX, tebufenozide + SX, tebufenpyrad + SX, tebupirimfos + SX, teflubenzuron + SX, tefluthrin + SX, temephos + SX, terbufos + SX, terpene constituents extracted from ant's grass of the extract of chenopodium ambrosioides near ambrosioides + SX, tetrachlorantraniliprole + SX, tetrachlorvinphos + SX,Tetradifon + SX, tetramethrin + SX, tetramethylfluthrin + SX, tetraniliprole + SX, theta-cypermethrin + SX, thiacloprid + SX, thiamethoxam + SX, thiocyclam + SX, thiodicarb + SX, thiofanox + SX, thiometon + SX, thiosultap disodium + SX, thiosultap monosodium + SX, thioantraniliprole + SX, tioxazafen + SX, tolfenpyrad + SX, tralomethrin + SX, transfluthrin + SX, triazamate + SX, triazophos + SX, trichlorfon + SX, trifluenfuronate + SX, triflumezopyrim + SX, triflumuron + SX, trimethacarb + SX, tyclopyrazoflor + SX, vamidothion + SX, Quassia amara wood extract + SX, 3,5-dimethylphenyl N-methylcarbamate (XMC) + SX, Xylylcarb + SX, Zeta-cypermethrin + SX,Zinc phosphide + SX, 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide (1241050-20-3) + SX, 3-methoxy-N-(5-{5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}indan-1-yl)propanamide (1118626-57-5) + SX, 2-({2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}imino)-3-(2,2,2-trifluoroethyl)-1,3-thiazolidin-4-one (1445683-71-5) + SX, (2Z)-2-({2-fluoro-4-methyl-5-[(R)-(2,2,2-trifluoroethyl)sulfinyl]phenyl}imino)-3-(2,2,2-trifluoroethyl)-1,3-thiazolidin-4-one (2377084-09-6) + SX, N-{4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2,2-pentafluoroethyl)-1H-pyrazole-3-carboxamide (1400768-21-9) + SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-2-(methanesulfonyl)propanamide (2396747-83-2) + SX, 1,4-dimethyl-2-[2-(pyridin-3-yl)-2H-indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3) + SX, 2-isopropyl-5-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0) + SX, N-({2-fluoro-4-[(2S,3S)-2-hydroxy-3-(3,4,5-trichlorophenyl)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl}methyl)cyclopropanecarboxamide + SX, 7-fluoro-N-[1-(methylsulfanyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfinyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfonyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, N-[1-(difluoromethyl)cyclopropyl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 2,9-dihydro-9-(methoxymethyl)-2-(pyridin-3-yl)-10H-pyrazolo[3,4-f]pyrido[2,3-b][1,4]oxazepin-10-one (2607927-97-7) + SX, BT crop protein Cry1Ab (BT crop protein Cry1Ab) + SX, BT crop protein Cry1Ac (BT crop protein Cry1Ac) + SX, BT crop protein Cry1Fa (BT crop protein Cry1Fa) + SX, BT crop protein Cry1A.105 (BT crop protein Cry1A.105) + SX, BT crop protein Cry2Ab (BT crop protein Cry2Ab) + SX,BT crop protein Vip3A + SX, BT crop protein mCry3A + SX, BT crop protein Cry3Ab + SX, BT crop protein Cry3Bb + SX, BT crop protein Cry34Ab1 / Cry35Ab1 + SX, Adoxophyes orana granulosis virus strain BV-0001 + SX, Anticarsia gemmatalis mNPV + SX, Autographa californica mNPV + SX, Cydia pomonella granulosis virus V15 (GV strain V15) + SX, Cydia pomonella granulosis virus V22 (GV strain V22) + SX, Cryptophlebia leucotreta granulosis virus (GV) + SX, Dendrolimus punctatus cypovirus (Dendrolimus punctatus cypovirus) + SX, Helicoverpa armigera NPV strain BV-0003 + SX, Helicoverpa zea NPV (NPV) + SX, Lymantria dispar NPV (NPV) + SX Mamestra brassicae NPV + SX, Mamestra configurata NPV + SX,Neodiprion abietis nucleopolyhedrosis virus (NPV) + SX, Neodiprion lecontei nucleopolyhedrosis virus (NPV) + SX, Neodiprion sertifer nucleopolyhedrosis virus (NPV) + SX, Nosema locustae + SX, Orgyia pseudotsugata nucleopolyhedrosis virus (NPV) + SX, Pieris rapae granulosis virus (GV) + SX, Plodia interpunctella granulosis virus (GV) + SX, Spodoptera exigua nucleopolyhedrosis virus (NPV) + SX, Spodoptera littoralis mNPV + SX, Spodoptera littoralis NPV + SX, Arthrobotrys dactyloides + SX, Bacillus firmus strain GB-126 + SX, Bacillus firmus strain I-1582 + SX, Bacillus firmus strain NCIM2637 + SX, Bacillus megaterium + SX, Bacillus sp. strain AQ175 + SX, Bacillus sp. strain AQ177 + SX, Bacillus sp. strain AQ178 + SX, Bacillus sphaericus strain 2362 serotype H5a5b + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus thuringiensis strain AQ52 + SX, Bacillus thuringiensis strain BD#32 + SX, Bacillus thuringiensis strain CR-371 + SX,Bacillus thuringiensis subsp. Aizawai strain ABTS-1857 + SX, Bacillus thuringiensis subsp. Aizawai strain AM65-52 + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX, Bacillus thuringiensis subsp. Aizawai strain NB200 + SX, Bacillus thuringiensis subsp. Aizawai Serotype strain H-7 + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX, Bacillus thuringiensis subsp. Kurstaki strain BMP123 + SX, Bacillus thuringiensis subsp. Kurstaki strain CCT1306) + SX, Bacillus thuringiensis subsp. Kurstaki strain EG2348 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG7841 + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810 + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-11 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX,Bacillus thuringiensis subsp. Tenebriosis strain NB176 + SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002 + SX, Bacillus thuringiensis subsp. morrisoni + SX, Bacillus thuringiensis var. colmeri + SX, Bacillus thuringiensis var. darmstadiensis strain 24-91 + SX, Bacillus thuringiensis var. dendrolimus + SX, Bacillus thuringiensis var. galleriae + SX, Bacillus thuringiensis var. israelensis strain BMP144 + SX, Bacillus thuringiensis var. israelensis serotype strain H-14 + SX, Bacillus thuringiensis var. japonensis strain buibui + SX, Bacillus thuringiensis var. san diego strain M-7 + SX, Bacillus thuringiensis var. 7216 + SX, Bacillus thuringiensis var. aegypti + SX, Bacillus thuringiensis var. T36 + SX, Beauveria bassiana strain ANT-03 + SX, Beauveria bassiana strain ATCC74040 + SX, Beauveria bassiana strain GHA + SX, Beauveria brongniartii + SX, Burkholderia rinogensis strain A396 + SX, Chromobacterium subtsugae strain PRAA4-1T + SX, Dactyllela ellipsospora + SX,Dectylaria thaumasia + SX, Hirsutella minnesotensis + SX, Hirsutella rhossiliensis + SX, Hirsutella thompsonii + SX, Lagenidium giganteum + SX, Lecanicillium lecanii strain KV01 + SX, Lecanicillium lecanii conidia of strain DAOM198499 + SX, Lecanicillium lecanii conidia of strain DAOM216596 + SX, Lecanicillium muscarium strain Ve6 + SX, Metarhizium anisopliae strain F52 + SX, Metarhizium anisopliae var. acridum + SX, Metarhizium anisopliae var. anisopliae BIPESCO 5 / F52 + SX, Metarhizium flavoviride + SX, Monacrosporium phymatopagum + SX, Paecilomyces fumosoroseus Apopka strain 97 + SX, Paecilomyces lilacinus strain 251 + SX, Paecilomyces tenuipes strain T1 + SX, Paenibacillus popilliae + SX, Pasteuria nishizawae strain Pn1 + SX, Pasteuria penetrans + SX, Pasteuria usgae + SX, Pasteuria thornei + SX, Serratia entomophila + SX, Verticillium chlamydosporium + SX, Verticillium lecani strain NCIM1312 + SX, Wolbachia pipientis + SX。,

[0039] Combinations of the present ingredient of the above group (b) with the compound of the present invention: acibenzolar-S-methyl + SX, aldimorph + SX, ametoctradin + SX, aminopyrifen + SX, amisulbrom + SX, anilazine + SX, azaconazole + SX, azoxystrobin + SX, basic copper sulfate + SX, benalaxyl + SX, benalaxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX, Benthiavalicarb-isopropyl + SX, benzovindiflupyr + SX, binapacryl + SX, biphenyl + SX, bitertanol + SX, bixafen + SX, blasticidin S + SX, Bordeaux mixture + SX, boscalid + SX, bromothalonil + SX, bromuconazole + SX, bupirimate + SX, captafol + SX, captan + SX, carbendazim + SX, carboxin + SX, carpropamid + SX, chinomethionate + SX, chitin + SX, chloroinconazide + SX, chloroneb + ​​SX,Chlorothalonil + SX, chlozolinate + SX, colletochlorin B + SX, copper(II) acetate + SX, copper(II) hydroxide + SX, copper oxychloride + SX, copper(II) sulfate + SX, coumoxystrobin + SX, cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cyproconazole + SX, cyprodinil + SX, dichlobentiazox + SX, Dichlofluanid + SX, diclocymet + SX, diclomezine + SX, dicloran + SX, diethofencarb + SX, difenoconazole + SX, diflumetorim + SX, dimethachlone + SX, dimethirimol + SX, dimethomorph + SX, dimoxystrobin + SX, diniconazole + SX, diniconazole-M + SX, dinocap + SX, dipotassium hydrogenphosphite + SX, dipymetitrone + SX, dithianon + SX,Dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt + SX, dodemorph + SX, dodine + SX, edifenphos + SX, enoxastrobin + SX, epoxiconazole + SX, etaconazole + SX, ethaboxam + SX, ethirimol + SX, etridiazole + SX, tea tree extract (Melaleuca alternifolia) + SX, extract of Reynoutria sachalinensis (Japanese knotweed) + SX, extract of the cotyledons of lupine plantlets ("BLAD") + SX, garlic extract (Allium sativum extract) + SX, horsetail extract (Equisetum arvense extract) + SX, nasturtium extract (Tropaeol majus extract) + SX, famoxadone + SX, fenamidone + SX, fenaminstrobin + SX, fenarimol + SX, fenbuconazole + SX, fenfuram + SX, fenhexamid + SX, fenoxanil + SX, fenpiclonil + SX, fenpicoxamid + SX, Fenpropidin + SX, Fenpropimorph + SX,Fenpyrazamine + SX, triphenyltin acetate + SX, triphenyltin chloride + SX, fentin hydroxide + SX, ferbam + SX, ferimzone + SX, florylpicoxamid + SX, fluazinam + SX, flubeneteram + SX, fludioxonil + SX, flufenoxadiazam + SX, flufenoxystrobin + SX, fluindapyr + SX, flumetylsulforim + SX, flumorph + SX, fluopicolide + SX, fluopyram + SX, fluopimomide + SX, fluoroimide + SX, fluoxapiprolin + SX, fluoxastrobin + SX, fluoxytioconazole + SX, fluquinconazole + SX, flusilazole + SX, flusulfamide + SX, flutianil + SX, flutolanil + SX, flutriafol + SX, fluxapyroxad + SX, folpet + SX, Fosetyl + SX, fosetyl-aluminium + SX, fuberidazole + SX, furalaxyl + SX, furametpyr + SX,Guazatine + SX, hexaconazole + SX, hymexazole + SX, imazalil + SX, imibenconazole + SX, iminoctadine + SX, iminoctadine triacetate + SX, inpyrfluxam + SX, iodocarb + SX, ipconazole + SX, ipfentrifluconazole + SX, ipflufenoquin + SX, iprobenfos + SX, iprodione + SX, iprovalicarb + SX Isofetamide + SX, isoflucipram + SX, isoprothiolane + SX, isopyrazam + SX, isotianil + SX, kasugamycin + SX, kresoxim-methyl + SX, laminarin + SX, oak leaves and bark of quercus + SX, mancozeb + SX, mandestrobin + SX, mandipropamid + SX, maneb + ​​SX, mefentrifluconazole + SX, mepanipyrim + SX, Mepronil + SX, meptyldinocap + SX, metalaxyl + SX, metalaxyl-M + SX, metarylpicoxamid + SX,Metconazole + SX, methasulfocarb + SX, metiram + SX, metominostrobin + SX, metrafenone + SX, metyltetraprole + SX, myclobutanil + SX, naftifine + SX, nuarimol + SX, octhilinone + SX, ofurace + SX, orysastrobin + SX, oxadixyl + SX, oxathiapiprolin + SX, oxine-copper + SX, oxolinic acid + SX, Oxpoconazole + SX, oxpoconazole fumarate + SX, oxycarboxin + SX, oxytetracycline + SX, pefurazoate + SX, penconazole + SX, pencycuron + SX, penflufen + SX, penthiopyrad + SX, phenamacril + SX, phosphorous acid + SX, phthalide + SX, picarbutrazox + SX, picoxystrobin + SX, piperalin + SX, polyoxins + SX, Potassium hydrogencarbonate + SX, potassium dihydrogenphosphite + SX,Probenazole + SX, prochloraz + SX, procymidone + SX, propamidine + SX, propamocarb + SX, propiconazole + SX, propineb + ​​SX, proquinazid + SX, prothiocarb + SX, prothioconazole + SX, pydiflumetofen + SX, pyraclostrobin + SX, pyrametostrobin + SX, pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, Pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridaclomethyl + SX, pyrifenox + SX, pyrimethanil + SX, pyrimorph + SX, pyriophenone + SX, pyrisoxazole + SX, pyroquilon + SX, Quillaja extract + SX, quinconazole + SX, quinofumelin + SX, quinoxyfen + SX, quintozene + SX, quinoa saponins Chenopodium quinoa + SX, seboctylamine + SX, sedaxane + SX, silthiofam + SX,Simeconazole + SX, sodium hydrogencarbonate + SX, spiroxamine + SX, streptomycin + SX, sulfur + SX, tebuconazole + SX, tebufloquin + SX, teclofthalam + SX, tecnazene + SX, terbinafine + SX, tetraconazole + SX, thiabendazole + SX, thifluzamide + SX, thiophanate + SX, thiophanate-methyl + SX, thiram + SX, Thymol + SX, tiadinil + SX, tolclofos-methyl + SX, tolfenpyrad + SX, tolprocarb + SX, tolylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX, triclopyricarb + SX, tricyclazole + SX, tridemorph + SX, trifloxystrobin + SX, triflumizole + SX, triforine + SX, triticonazole + SX, Validamycin + SX, valifenalate + SX, vinclozolin + SX,マスタードパウダー(yellow mustard powder) + SX, zinc thiazole + SX, ジネブ(zineb) + SX, ジラム(ziram) + SX, ゾキサミド(zoxamide) + SX, N'-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91-6) + SX, N'-{4-[(4,5-dichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6) + SX, N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylmethanimidamide (1052688-31-9) + SX, N '-[5-chloro-4-(2-fluorophenoxy)-2-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055589-28-9) + SX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055756-21-1) + SX, N'-(2-chloro-4-phenoxy-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2062599-39-5) + SX, N'-[4-(1-hydroxy-1-phenyl-2,2,2-trifluoroethyl)-2-methyl-5-methoxyphenyl]-N-isopropyl-N-methylmethanimidamide (2101814-55-3) + SX, N'-[5-bromo-6-(1-methyl-2-propoxyethoxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylmethanimidamide (1817828-69-5) + SX,4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (1362477-26-6) + SX, 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056-97-5) + SX, ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate (39491-78-6) + SX, N-[(2-chlorothiazol-5-yl)methyl]-N-ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8) + SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4) + SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2) + SX, (1S, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-07-3) + SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6) + SX, (1R, 2S, 5S)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R,5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-09-5) + SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxy-1-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-carboxylate (1791398-02-1) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-bromo-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-86-0) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-chloro-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-84-8) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13-5) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018317-25-2) + SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082661-43-4) + SX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1) + SX,methyl ({2-methyl-5-[1-(4-methoxy-2-methylphenyl)-1H-pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8) + SX, 2-(difluoromethyl)-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1616239-21-4) + SX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-02-9) + SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-05-2) + SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-27-0) + SX, (2E,3Z)-5-{[1-(2,4-dichlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3) + SX, 5-chloro-4-({2-[6-(4-chlorophenoxy)pyridin-3-yl]ethyl}amino)-6-methylpyrimidine (1605340-92-8) + SX, N-(1-benzyl-1,3-dimethylbutyl)-8-fluoroquinoline-3-carboxamide (2132414-04-9) + SX, N-(1-benzyl-3,3,3-trifluoro-1-methylpropyl)-8-fluoroquinoline-3-carboxamide (2132414-00-5) + SX, 4,4-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-25-1) + SX, 5,5-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-26-2) + SX, N-ethyl-2-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N,2-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-methoxy-N'-methyl-N-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N'-ethyl-N-methoxy-N-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N'-dimethoxy-N-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-acetyl-2-(ethanesulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9) + SX,3-(4-bromo-7-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromoindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromo-4-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)acetamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)butanamide + SX, N-methoxy-N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N-diethyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX,1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 4-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)morpholin-3-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one + SX, 3,3-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1,2-oxazinan-3-one + SX, 1-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)azepan-2-one + SX, 4,4-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 5-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, ethyl 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxylate + SX, N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-propyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N,N-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-1,2,4-triazol-3-amine + SX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + SX, methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, ethyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, methyl 2-[2-(trifluoromethyl)-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, 1-(2,3-dimethylpyridin-5-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-[2-(difluoromethyl)-3-methylpyridin-5-yl]-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 2,2-difluoro-N-[6-({[1-(1-methyl-1H-tetrazol-5-yl)benzimidazol-2-yl]oxy}methyl)pyridin-2-yl]-2-phenoxyacetamide + SX, 1-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile + SX, ethyl 1-[(4-{[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, ethyl 1-[(4-{[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(spiro[3.4]octan-1-yl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-hexyl-5-methylthiazole-4-carboxamide + SX, 2-[acetyl(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methoxyacetyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methylpropanoyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(3,5-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(6-chloropyridin-3-yl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N- [1-(2,6-difluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluoro-3-methoxyphenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-{[1-(2,6-difluorophenyl)cyclopropyl]oxy}pyrimidine + SX, 3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(4-bromo-2-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX,(5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, Agrobacterium radiobactor strain K1026 + SX, Agrobacterium radiobactor strain K84 + SX, Bacillus amyloliquefaciens strain PTA-4838 (Aveo™ EZ Nematicide) + SX, Bacillus amyloliquefaciens strain AT332 + SX, Bacillus amyloliquefaciens strain B3 + SX, Bacillus amyloliquefaciens strain D747 + SX, Bacillus amyloliquefaciens strain DB101 + SX, Bacillus amyloliquefaciens strain DB102 + SX, Bacillus amyloliquefaciens strain GB03 + SX, Bacillus amyloliquefaciens strain FZB24 + SX, Bacillus amyloliquefaciens strain FZB42 + SX, Bacillus amyloliquefaciens strain IN937a + SX, Bacillus amyloliquefaciens strain MBI600 + SX, Bacillus amyloliquefaciens strain QST713 + SX, Bacillus amyloliquefaciens isolate strain B246 + SX,Bacillus amyloliquefaciens strain F727 + SX, Bacillus amyloliquefaciens subsp. plantarum strain D747 + SX, Bacillus licheniformis strain HB-2 + SX, Bacillus licheniformis strain SB3086 + SX, Bacillus pumilus strain AQ717 + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 + SX, Bacillus pumilus strain QST2808 + SX, Bacillus simplex strain CGF2856 + SX, Bacillus subtilis strain AQ153 + SX, Bacillus subtilis strain AQ743 + SX, Bacillus subtilis strain BU1814 + SX, Bacillus subtilis strain D747 + SX, Bacillus subtilis strain DB101 + SX, Bacillus subtilis strain FZB24 + SX, Bacillus subtilis strain GB03 + SX, Bacillus subtilis strain HAI0404 + SX, Bacillus subtilis strain IAB / BS03 + SX, Bacillus subtilis strain MBI600 + SX, Bacillus subtilis strain QST30002 / AQ30002 + SX, Bacillus subtilis strain QST30004 / AQ30004 + SX, Bacillus subtilis strain QST713 + SX, Bacillus subtilis strain QST714 + SX, Bacillus subtilis var. Amyloliquefaciens strain FZB24 + SX,Bacillus subtilis strain Y1336 + SX, Burkholderia cepacia + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia type Wisconsin strain M54 + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Chaetomium cupreum + SX, Clonostachys rosea + SX, Coniothyrium minitans strain CGMCC8325 + SX, Coniothyrium minitans strain CON / M / 91-8 + SX, cryptococcus albidus + SX, Erwinia carotovora subsp. carotovora strain CGE234M403 + SX, Fusarium oxysporum strain Fo47 + SX, Gliocladium catenulatum strain J1446 + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 + SX, Pantoea agglomerans strain E325 + SX, Phlebiopsis gigantea strain VRA1992 + SX, Pseudomonas aureofaciens strain TX-1 + SX, Pseudomonas chlororaphis strain 63-28 + SX, Pseudomonas chlororaphis strain AFS009 + SX, Pseudomonas chlororaphis strain MA342 + SX, Pseudomonas fluorescens strain 1629RS + SX, Pseudomonas fluorescens strain A506 + SX,Pseudomonas fluorescens strain CL145A + SX, Pseudomonas fluorescens strain G7090 + SX, Pseudomonas sp. strain CAB-02 + SX, Pseudomonas syringae strain 742RS + SX, Pseudomonas syringae strain MA-4 + SX, Pseudozyma flocculosa strain PF-A22UL + SX, Pseudomonas rhodesiae strain HAI-0804 + SX, Pythium oligandrum strain DV74 + SX, Pythium oligandrum strain M1 + SX, Streptomyces griseoviridis strain K61 + SX, Streptomyces lydicus strain WYCD108US + SX, Streptomyces lydicus strain WYEC108 + SX, Talaromyces flavus strain SAY-Y-94-01 + SX, Talaromyces flavus strain V117b + SX, Trichoderma asperellum strain ICC012 + SX, Trichoderma asperellum SKT-1 + SX, Trichoderma asperellum strain T25 + SX, Trichoderma asperellum strain T34 + SX, Trichoderma asperellum strain TV1 + SX, Trichoderma atroviride strain CNCM 1-1237 + SX, Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain IMI 206040 + SX, Trichoderma atroviride strain SC1 + SX, Trichoderma atroviride strain SKT-1 + SX,Trichoderma atroviride strain T11 + SX, Trichoderma gamsii strain ICC080 + SX, Trichoderma harzianum strain 21 + SX, Trichoderma harzianum strain DB104 + SX, Trichoderma harzianum strain DSM 14944 + SX, Trichoderma harzianum strain ESALQ-1303 + SX, Trichoderma harzianum strain ESALQ-1306 + SX, Trichoderma harzianum strain IIHR-Th-2 + SX, Trichoderma harzianum strain ITEM908 + SX, Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum strain T22 + SX, Trichoderma harzianum strain T39 + SX, Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma polysporum strain IMI206039 + SX, trichoderma stromaticum + SX, Trichoderma virens strain G-41 + SX, Trichoderma virens strain GL-21 + SX, Trichoderma viride + SX, Variovorax paradoxus strain CGF4526 + SX, Harpin protein + SX。,

[0040] Combinations of the present ingredient in group (c) above with the compound of the present invention: 1-methylcyclopropene + SX, 1,3-diphenylurea + SX, 2,3,5-triiodobenzoic acid + SX, (1H-indol-3-yl)acetic acid (IAA) + SX, 4-(1H-indol-3-yl)butyric acid (IBA) + SX, 2-(4-chloro-2-methylphenoxy)acetic acid (MCPA) + SX, 4-(4-chloro-2-methylphenoxy)butyric acid (MCPB) + SX, 4-chlorophenoxyacetic acid (4-CPA) + SX, 5-aminolevulinic acid hydrochloride + SX, 6-benzylaminopurine + SX, abscisic acid + SX, AVG (aminoethoxyvinylglycine) + SX, anisiflupurin + SX, ancymidol + SX, butralin + SX, calcium carbonate + SX, calcium chloride + SX, calcium formate + SX, calcium peroxide + SX, calcium polysulfide + SX, calcium sulfate + SX, chlormequat chloride + SX, chlorpropham + SX, choline chloride + SX, cloprop + SX, cyanamide + SX, Cyclanilide + SX,Daminozide + SX, decan-1-ol + SX, dichlorprop + SX, dikegulac + SX, dimethipin + SX, diquat + SX, ethephon + SX, ethychlozate + SX, flumetralin + SX, flurprimidol + SX, forchlorfenuron + SX, formononetin + SX, gibberellin A + SX, gibberellin A3 + SX, inabenfide + SX, Kinetin + SX, lipochitooligosaccharide SP104 + SX, maleic hydrazide + SX, mefluidide + SX, mepiquat chloride + SX, oxidized glutathione + SX, paclobutrazol + SX, pendimethalin + SX, prohexadione calcium + SX, prohydrojasmon + SX, pyraflufen-ethyl + SX, sintophen + SX, sodium 1-naphthaleneacetate + SX, sodium cyanate + SX, Thidiazuron + SX, triapenthenol + SX, tribufos + SX, trinexapac-ethyl + SX,Uniconazole-P + SX, 2-(naphthalen-1-yl)acetamide + SX, [4-oxo-4-(2-phenylethyl)amino]butyric acid + SX, Methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate + SX, 3-[(6-chloro-4-phenylquinazolin-2-yl)amino]propan-1-ol + SX, Claroideoglomus etunicatum + SX, Claroideoglomus claroideum + SX, Funneliformis mosseae + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus aggregatum + SX, Glomus deserticola + SX, Glomus monosporum + SX, Paraglomus brasillianum + SX, Rhizophagus clarus + SX, Rhizophagus intraradices RTI-801 + SX, Rhizophagus irregularis DAOM 197198 + SX, Azorhizobium caulinodans + SX, Azospirillum amazonense + SX, Azospirillum brasilense XOH + SX, Azospirillum brasilense Ab-V5 + SX, Azospirillum brasilense Ab-V6 + SX, Azospirillum caulinodans + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azospirillum lipoferum + SX, Bradyrhizobium elkanii SEMIA 587 + SX, Bradyrhizobium elkanii SEMIA 5019 + SX, Bradyrhizobium japonicum TA-11 + SX,Bradyrhizobium japonicum USDA 110 + SX, Bradyrhizobium liaoningense + SX, Bradyrhizobium lupini + SX, Delftia acidovorans RAY209 + SX, Mesorhizobium ciceri + SX, Mesorhizobium huakii + SX, Mesorhizobium loti + SX, Rhizobium etli + SX, Rhizobium galegae + SX, Rhizobium leguminosarum bv. Phaseoli + SX, Rhizobium leguminosarum bv. Trifolii + SX, Rhizobium leguminosarum bv. Viciae + SX, Rhizobium trifolii + SX, Rhizobium tropici + SX, Sinorhizobium fredii + SX, Sinorhizobium meliloti + SX, Zucchini Yellow Mosaik Virus weak strain + SX. ,

[0041] Combinations of the present component of the above group (d) with the compound of the present invention: anthraquinone + SX, deet + SX, icaridin + SX.

[0042] The ratio of the compound of the present invention to the present component is not particularly limited, and examples thereof include a weight ratio (compound of the present invention:present component) of 1000:1 to 1:1000, 500:1 to 1:500, 100:1 to 1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, 1:50, and the like.

[0043] The present compound or the compound of the present invention is effective against arthropod pests (herein referred to as resistant arthropod pests), mollusks and nematodes that have reduced sensitivity (also referred to as being resistant) to specific insecticides, acaricides, molluscs and nematodes. Examples of such insecticides, acaricides, molluscs and nematodes include those in groups a1 to a26. Group a1: Acetylcholinesterase inhibitors Group 1A carbamates and Group 1B organophosphorus compounds in the IRAC classification, such as alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl (NAC), carbofuran, carbosulfan, ethiofencarb, fenobucarb (BPMC), formetanate, furathiocarb, isoprocarb (MIPC), methiocarb, methomyl, methoxychlor (methox ychlor), metolcarb (metolcarb), oxamyl (oxamyl), pirimicarb (pirimicarb), promecarb (promecarb), propoxur (propoxur: PHC), thiodicarb (thiodicarb), thiofanox (thiofanox), triazamate (triazamate), trimethacarb (trimethacarb), xylylcarb (xylylcarb); acephate (acephate), azamethiphos (azamethiphos), azinphos ethyl (azinphos-ethyl), azinphos methyl (azinphos-methyl), cadusafos (cadusafos), chlorethoxyfos (chlorethoxyfos), chlorfenvinphos (chlorfenvinphos), chlormephos (chlormephos), chlorpyrifos (chlorpyrifos),Chlorpyrifos-methyl, coumaphos, cyanophos (CYAP), demeton, demeton-S-methyl, diazinon, dichlorvos (DDVP), dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion ( Ethion), ethoprophos, famphur, fenamiphos, fenchlorphos, fenitrothion (MEP), fenthion (MPP), fosthiazate, heptenophos, imicyaphos, isofenphos, isopropyl-O-(methoxyaminothiophosphoryl) salicylate propyl-O-(methoxyaminothiophosphoryl) salicylate), isoxathion, malathion, mecarbam, methamidophos, methidathion (DMTP), mevinphos, monocrotophos, naled (BRP), omethoate, oxydemeton-methyl ethyl), parathion, parathion-methyl, phenthoate (PAP), phorate, phosalone, phosmet (PMP), phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prothiofos,A group consisting of pyraclofos, pyrazophos, pyridaphenthion, quinalphos, sulfotep, sulprofos, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, toxaphene, triazophos, trichlorfon (DEP), and vamidothion. Group a2: GABAergic chloride ion channel blockers A group consisting of Group 2A cyclic diene organochlorines and Group 2B phenylpyrazole compounds in the IRAC classification, such as chlordane, endosulfan, dieldrin, ethiprole, fipronil, flufiprole, and pyriprole. Group a3: Sodium channel modulators A group consisting of Group 3A pyrethroids and Group 3B compounds in the IRAC classification, such as acrinathrin, allethrin, bifenthrin, kappa-bifenthrin, bioallethrin, bioresmethrin, cycloprothrin, cyfluthrin, and benzylparaben. beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin,Zeta-cypermethrin, sigma-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, etofenprox , fenpropathrin, fenvalerate, flucythrinate, flumethrin, fluvalinate, tau-fluvalinate, halfenprox, heptafluthrin, imiprothrin, kadethrin, meperfluthrin, momfluorothrin, permethrin, phenothrin, prallethrin, pyrethrins, resmethrin, silafluofen, tefluthrin, kappa-tefluthrin a group consisting of tetramethrin, tetramethylfluthrin, tralomethrin, transfluthrin, benfluthrin, flufenprox, flumethrin, furamethrin, metofluthrin, profluthrin, dimefluthrin, and DDT. Group a4: Nicotinic acetylcholine receptor competitive modulators Group 4A neonicotinoids, 4B nicotine, 4C sulfoximines, 4D butenolides, and 4E mesoions according to the IRAC classification, for example, acetamiprid.A group consisting of clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, flupyradifurone, sulfoxaflor, cycloxaprid, triflumezopyrim, dichloromezotiaz and flupirimine. Group a5: Nicotinic acetylcholine receptor allosteric modulators A group consisting of Group 5 spinosyns in the IRAC action classification, for example, spinosad and spinetoram. Group a6: glutamate-gated chloride channel allosteric modulators Group 6 of the IRAC action classification: a group consisting of abamectins and milbemycins, for example, abamectin, emamectin benzoate, lepimectin, milbemectin, dimadectin, doramectin, eprinomectin, ivermectin, latidectin, selamectin, milbemycin D, moxidectin, and nemadectin. Group a7: Juvenile hormone mimics A group consisting of Group 7A juvenile hormone analogues, Group 7B fenoxycarb and 7C pyriproxyfen in the IRAC action classification, for example, hydroprene, kinoprene, methoprene, fenoxycarb and pyriproxyfen. Group a8: Chordotonal organ TRPV channel modulators A group consisting of Group 9 pyridine azomethine derivatives in the IRAC action classification, for example,The group consisting of Pymetrozine and Pyrifluquinazon. Group a9: Microbial-derived insect midgut membrane disrupting agents IRAC classification group 11A Bacillus thuringiensis, group 11B Bacillus sphaericus, for example, Bacillus sphaericus, Bacillus thuringiensis strain BD#32, Bacillus thuringiensis strain AQ52, Bacillus thuringiensis subsp. aizawai strain ABTS-1857, Bacillus thuringiensis subsp. kurstaki strain HD-1 HD-1), Bacillus thuringiensis subsp. kurstaki strain BMP123, Bacillus thuringiensis subsp. Tenebriosis strain NB176, Bacillus thuringiensis var. israelensis, Bacillus thuringiensis var. aegypti, Bacillus thuringiensis var. colmeri, Bacillus thuringiensis var. darmstadiensis), Bacillus thuringiensis var. dendrolimus,Bacillus thuringiensis var. galleriae, Bacillus thuringiensis var. japonensis, Bacillus thuringiensis subsp. morrisoni, Bacillus thuringiensis var. san diego, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002, Bacillus thuringiensis var. 7216, Bacillus thuringiensis var. T36 T36), delta-endotoxins that confer resistance to lepidopteran insects (e.g., Cry1A, Cry1Ab, modified Cry1Ab (partially deleted Cry1Ab), Cry1Ac, Cry1Ab-Ac (hybrid protein in which Cry1Ab and Cry1Ac are fused), Cry1C, Cry1F, Cry1Fa2 (modified Cry1F), moCry1F (modified Cry1F), Cry1A.105 (Cry1Ab, Cry1Ac, Cry1Ab, Cry1Ab, Cry1Ab, Cry1Ab-Ac), Cry1C, Cry1F, Cry1Fa2 (modified Cry1F), moCry1F (modified Cry1F), Cry1A.105 (Cry1Ab, Cry1Ac, Cry1Ab ... Group a10: Oxidative phosphorylation uncouplers that disrupt the proton gradient Group 13 compounds in the IRAC action classification, for example,A group consisting of chlorfenapyr and sulfluramid. Group a11: Nicotinic acetylcholine receptor channel blockers A group consisting of Group 14 nereistoxin analogues in the IRAC action classification, such as bensultap, cartap, cartap hydrochloride, thiocyclam, thiosultap disodium, and thiosultap monosodium. Group a12: Chitin biosynthesis inhibitors A group consisting of Group 15 benzoylureas and Group 16 buprofezin in the IRAC classification of action, such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron, and buprofezin. Group a13: Molting inhibitors A group consisting of Group 17 compounds in the IRAC classification of action, such as cyromazine. Group a14: ecdysone receptor agonists Group 18 diacylhydrazines in the IRAC classification, such as chromafenozide, halofenozide, methoxyfenozide, and tebufenozide. Group a15: voltage-dependent sodium channel blockers Group 22A oxadiazines and Group 22B semicarbazones in the IRAC classification, such asa group consisting of indoxacarb and metaflumizone. Group a16: acetyl-CoA carboxylase inhibitors A group consisting of Group 23 tetronic acid and tetramic acid derivatives in the IRAC action classification, such as spirodiclofen, spiromesifen, and spirotetramat. Group a17: ryanodine receptor modulators A group consisting of Group 28 diamides in the IRAC action classification, such as chlorantraniliprole, cyantraniliprole, cycloniliprole, flubendiamide, tetraniliprole, cyhalodiamide, and tetrachlorantraniliprole. Group a18: Chordotonal organ modulators A group consisting of Group 29 compounds in the IRAC classification, for example, flonicamid. Group a19: Mite growth inhibitors A group consisting of Group 10 compounds in the IRAC classification, for example, etoxazole, clofentezine, and hexythiazox. Group a20: Octopamine receptor agonists A group consisting of Group 19 compounds in the IRAC classification, for example, amitraz. Group a21: Mitochondrial electron transport chain complex IV inhibitors A group consisting of Group 24 compounds in the IRAC classification, for example, phosphines. Group a22: Isoxazoline compounds, for example, afoxolaner, fluralaner, sarolaner, and lotilaner. Group a23: Mitochondrial ATP synthase inhibitors Group 12 compounds according to the IRAC classification of action, for example:Group a24: Mitochondrial electron transport complex III inhibitors Group 20 compounds in the IRAC classification, such as acequinocyl and bifenazate. Group a25: Mitochondrial electron transport complex I inhibitors (METIs) Group 21 compounds in the IRAC classification, such as pyridaben and fenpyroximate. Group a26: Azadirachtin and pyridalyl.

[0044] Factors that may reduce susceptibility include: [1] amino acid substitution in the target protein; [2] reduction in the target protein; [3] enhanced metabolism; [4] reduced skin permeability; and [5] enhanced excretion by membrane transporters. In [1], the target protein may have one or more amino acid substitutions. The enhanced metabolism in [3] refers to increased activity of metabolic enzymes (also known as detoxification enzymes) such as cytochrome P450, carboxylesterase, and glutathione S-transferase. Factors that may reduce susceptibility include one or more of the following: [1] amino acid substitution in the target protein; [2] reduction in the target protein; [3] enhanced metabolism; [4] reduced skin permeability; and [5] enhanced excretion by membrane transporters.

[0045] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes with reduced susceptibility include the following. Hemiptera with reduced sensitivity to one or more compounds selected from group a2; Hemiptera with reduced sensitivity to one or more compounds selected from group a4; Hemiptera with reduced sensitivity to one or more compounds selected from group a8; Hemiptera with reduced sensitivity to one or more compounds selected from group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4; Hemiptera with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a8; Hemiptera with reduced sensitivity to one or more compounds selected from group a2 and buprofezin belonging to group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a4 and one or more compounds selected from group a8; Hemiptera with reduced sensitivity to one or more compounds selected from group a4 and buprofezin belonging to group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a8 and buprofezin belonging to group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4 and one or more compounds selected from group a8; Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4 and buprofezin belonging to group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a8 and buprofezin belonging to group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a4, one or more compounds selected from group a8 and buprofezin belonging to group a12; Hemiptera having reduced susceptibility to one or more compounds selected from group a2, one or more compounds selected from group a4, one or more compounds selected from group a8, and buprofezin belonging to group a12; Delphacidae having reduced susceptibility to one or more compounds selected from group a2; Delphacidae having reduced susceptibility to one or more compounds selected from group a4; Delphacidae having reduced susceptibility to one or more compounds selected from group a8;Planthoppers having reduced susceptibility to one or more compounds selected from Group a12; Planthoppers having reduced susceptibility to one or more compounds selected from Group a2 and one or more compounds selected from Group a4; Planthoppers having reduced susceptibility to one or more compounds selected from Group a2 and pymetrozine belonging to Group a8; Planthoppers having reduced susceptibility to one or more compounds selected from Group a2 and buprofezin belonging to Group a12; Planthoppers having reduced susceptibility to one or more compounds selected from Group a4 and pymetrozine belonging to Group a8; Planthoppers having reduced susceptibility to one or more compounds selected from Group a4 and buprofezin belonging to Group a12; Planthoppers having reduced susceptibility to one or more compounds selected from Group a2, one or more compounds selected from Group a4, and pymetrozine belonging to Group a8; Planthoppers having reduced sensitivity to one or more compounds selected from Group a2, one or more compounds selected from Group a4, and buprofezin belonging to Group a12; Planthoppers having reduced sensitivity to one or more compounds selected from Group a2, pymetrozine belonging to Group a8, and buprofezin belonging to Group a12; Planthoppers having reduced sensitivity to one or more compounds selected from Group a4, pymetrozine belonging to Group a8, and buprofezin belonging to Group a12; Planthoppers having reduced sensitivity to one or more compounds selected from Group a2, one or more compounds selected from Group a4, pymetrozine belonging to Group a8, and buprofezin belonging to Group a12; Brown planthoppers, white-backed planthoppers, or small brown planthoppers having reduced sensitivity to one or more compounds selected from Group a2; Brown planthoppers, white-backed planthoppers, or small brown planthoppers having reduced sensitivity to one or more compounds selected from Group a4; brown planthoppers, white-backed planthoppers, or small brown planthoppers having reduced susceptibility to one or more compounds selected from group a8; brown planthoppers, white-backed planthoppers, or small brown planthoppers having reduced susceptibility to one or more compounds selected from group a12; brown planthoppers, white-backed planthoppers, or small brown planthoppers having reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4;brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from group a2 and pymetrozine belonging to group a8; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from group a2 and buprofezin belonging to group a12; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from group a4 and pymetrozine belonging to group a8; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from group a4 and buprofezin belonging to group a12; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from group a2, one or more compounds selected from group a4 and group a8; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to pymetrozine brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from Group a2, one or more compounds selected from Group a4, and buprofezin belonging to Group a12; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from Group a2, pymetrozine belonging to Group a8, and buprofezin belonging to Group a12; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from Group a4, pymetrozine belonging to Group a8, and buprofezin belonging to Group a12; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from Group a2, one or more compounds selected from Group a4, pymetrozine belonging to Group a8, and buprofezin belonging to Group a12; brown planthoppers, white-backed planthoppers or small brown planthoppers having reduced sensitivity to one or more compounds selected from Group a2, one or more compounds selected from Group a4, pymetrozine belonging to Group a8, and buprofezin belonging to Group a12; Aphididae with reduced susceptibility to one or more compounds selected from group a3; Aphididae with reduced susceptibility to one or more compounds selected from group a8; Aphididae with reduced susceptibility to one or more compounds selected from group a3 and one or more compounds selected from group a4; Aphididae with reduced susceptibility to one or more compounds selected from group a3 and one or more compounds selected from group a8; Aphididae with reduced susceptibility to one or more compounds selected from group a4 and one or more compounds selected from group a8;aphids having reduced susceptibility to one or more compounds selected from group a3, one or more compounds selected from group a4, and one or more compounds selected from group a8; green peach aphids having reduced susceptibility to one or more compounds selected from group a1; cotton aphids or green peach aphids having reduced susceptibility to one or more compounds selected from group a3; cotton aphids or green peach aphids having reduced susceptibility to one or more compounds selected from group a4; cotton aphids or green peach aphids having reduced susceptibility to one or more compounds selected from group a8; cotton aphids or green peach aphids having reduced susceptibility to one or more compounds selected from group a3 and one or more compounds selected from group a4; cotton aphids or green peach aphids having reduced susceptibility to one or more compounds selected from group a3 and one or more compounds selected from group a8; cotton aphid or green peach aphid having reduced susceptibility to one or more compounds selected from group a4 and one or more compounds selected from group a8; cotton aphid or green peach aphid having reduced susceptibility to one or more compounds selected from group a3, one or more compounds selected from group a4 and one or more compounds selected from group a8; sweet potato whitefly having reduced susceptibility to one or more compounds selected from group a3; sweet potato whitefly having reduced susceptibility to one or more compounds selected from group a4; green peach aphid having reduced susceptibility to one or more compounds selected from group a1; cotton aphid having reduced susceptibility to carbamate compounds selected from group a1 and / or organophosphate compounds selected from group a1; brown planthoppers with reduced susceptibility to malathion, chlorpyrifos, diazinon, fenobucarb, carbofuran, ethiprole, fipronil, flufiprole, etofenprox, dinotefuran, imidacloprid, nitenpyram, sulfoxaflor, thiacloprid, thiamethoxam, pymetrozine, and / or buprofezin; white-backed planthoppers with reduced susceptibility to isoprocarb, chlorpyrifos, imidacloprid, and / or buprofezin;Amrasca biguttula biguttula with reduced susceptibility to imidacloprid, thiamethoxam, acetamiprid, thiacloprid, clothianidin, and / or dinotefuran; cotton aphid with reduced susceptibility to pirimicarb and / or organophosphate compounds selected from group a1; green peach aphid with reduced susceptibility to triazamate, pirimicarb, endosulfan, deltamethrin, lambda-cyhalothrin, DDT, and / or imidacloprid; lettuce aphid with reduced susceptibility to pirimicarb, methomyl, acephate, dieldrin, and / or endosulfan; English grain aphid with reduced susceptibility to lambda-cyhalothrin; greenhouse whitefly with reduced susceptibility to one or more compounds selected from group a4, bifenthrin, and / or spiromesifen; Bemisia tabaci with reduced susceptibility to pirimiphos-methyl, profenofos, endosulfan, fipronil, lambda-cyhalothrin, bifenthrin, alpha-cypermethrin, cartap, buprofezin, spiromesifen, chlorantraniliprole, diafenthiuron, and / or azadirachtin; Asian citrus psyllid with reduced susceptibility to chlorpyrifos, bifenthrin, cypermethrin, acetamiprid, imidacloprid, thiamethoxam, nitenpyram, and / or chlorfenapyr; Brown stink bug with reduced susceptibility to monocrotophos, methamidophos, acephate, endosulfan, beta-cyfluthrin, and / or imidacloprid; Lepidoptera with reduced susceptibility to one or more compounds selected from group a14; Lepidoptera with reduced susceptibility to one or more compounds selected from group a15; Lepidoptera with reduced susceptibility to one or more compounds selected from group a17; Lepidoptera with reduced susceptibility to one or more compounds selected from group a14 and one or more compounds selected from group a17; Diamondback moth with reduced susceptibility to one or more compounds selected from group a15; Diamondback moth with reduced susceptibility to one or more compounds selected from group a17; Rice leafroller with reduced susceptibility to one or more compounds selected from group a14;Rice leafrollers having reduced susceptibility to one or more compounds selected from group a17; Rice leafrollers having reduced susceptibility to one or more compounds selected from group a14 and one or more compounds selected from group a17; Helicoverpa armigera having reduced susceptibility to one or more compounds selected from group a3; Helicoverpa armigera having reduced susceptibility to one or more compounds selected from group a9; Corn earworms having reduced susceptibility to one or more compounds selected from group a9; Tea tortrix moths having reduced susceptibility to one or more compounds selected from group a14; Tea tortrix moths having reduced susceptibility to one or more compounds selected from group a17; Smaller tea tortrix moths having reduced susceptibility to one or more compounds selected from group a14; Smaller tea tortrix moths having reduced susceptibility to one or more compounds selected from group a17; Smaller tea tortrix moths having reduced susceptibility to one or more compounds selected from group a14 and one or more compounds selected from group a17; Smaller tea tortrix moths having reduced susceptibility to one or more compounds selected from group a14 and one or more compounds selected from group a17; Diamondback moth with reduced susceptibility to one or more compounds selected from group a3; Tuta absoluta with reduced susceptibility to one or more compounds selected from group a17; Rice stem borer with reduced susceptibility to endosulfan, fipronil, and / or thiosultap monosodium salt; European corn borer with reduced susceptibility to deltamethrin and / or lambda-cyhalothrin; Sugarcane borer with reduced susceptibility to delta-endotoxins Cry1Ab and / or Cry1Ac; Eggplant fruit borer with reduced susceptibility to profenofos, carbaryl, chlorpyrifos, endosulfan, deltamethrin, and / or fenvalerate; Spodoptera litura with reduced susceptibility to profenofos, chlorpyrifos, quinalphos, phoxim, triazophos, methomyl, thiodicarb, endosulfan, fipronil, cypermethrin, deltamethrin, beta-cyfluthrin, spinosad, abamectin, emamectin benzoate, lufenuron, diflubenzuron, methoxyfenozide, and / or indoxacarb;beet armyworms with reduced susceptibility to chlorpyrifos, deltamethrin, cypermethrin, spinosad, abamectin, emamectin benzoate, lufenuron, indoxacarb, and / or methoxyfenozide; armyworms with reduced susceptibility to the delta-endotoxins Cry1Ab, Cry1Ac, Cry2Ab2, Cry2Ae, and / or Cry1F; tobacco budworms with reduced susceptibility to sulprofos, profenofos, monocrotophos, parathion-methyl, thiodicarb, methomyl, toxaphene, endosulfan, cypermethrin, deltamethrin, DDT, and / or spinosad; Helicoverpa armigera with reduced susceptibility to monocrotophos, chlorpyrifos, profenofos, methomyl, thiodicarb, toxaphene, endosulfan, fenvalerate, deltamethrin, cypermethrin, DDT, indoxacarb, and / or chlorantraniliprole; Corn earworm with reduced susceptibility to parathion-methyl, cypermethrin, endosulfan, and / or DDT; Codling moth with reduced susceptibility to lambda-cyhalothrin, thiacloprid, and / or methoxyfenozide; European grape wine moth with reduced susceptibility to deltamethrin and / or indoxacarb; Diamondback moths with reduced susceptibility to methomyl, dieldrin, permethrin, fipronil, spinosad, abamectin, emamectin benzoate, delta-endotoxin Cry1C, lufenuron, indoxacarb, chlorantraniliprole, flubendiamide, and / or diafenthiuron; Thysanoptera with reduced susceptibility to one or more compounds selected from group a2; Thysanoptera with reduced susceptibility to one or more compounds selected from group a3; Thysanoptera with reduced susceptibility to one or more compounds selected from group a4; Thysanoptera with reduced susceptibility to one or more compounds selected from group a9; Thysanoptera with reduced susceptibility to one or more compounds selected from group a17; Onion thrips with reduced susceptibility to one or more compounds selected from group a3; Onion thrips with reduced susceptibility to profenofos, chlorpyrifos, deltamethrin and / or lambda-cyhalothrin;western flower thrips having reduced susceptibility to methiocarb, methomyl, bendiocarb, formetanate, carbofuran, malathion, chlorpyrifos, diazinon, methamidophos, dimethoate, dichlorvos, acephate, methidathion, toxaphene, endosulfan, fipronil, acrinathrin, alphacypermethrin, bifenthrin, deltamethrin, esfenvalerate, permethrin, taufluvalinate, cypermethrin, fenvalerate, cyfluthrin, imidacloprid, spinosad, spinetoram, abamectin, pyriproxyfen, and / or cyantranylprole; diptera having reduced susceptibility to one or more compounds selected from group a2; diptera having reduced susceptibility to one or more compounds selected from group a3; Diptera with reduced susceptibility to one or more compounds selected from group a4; Diptera with reduced susceptibility to one or more compounds selected from group a9; Diptera with reduced susceptibility to one or more compounds selected from group a17; Tomato leafminers with reduced susceptibility to permethrin and / or fenvalerate; Bean leafminers with reduced susceptibility to methamidophos, parathion-methyl, pyrazophos, demeton, chlorpyrifos, triazophos, permethrin, cypermethrin, DDT, spinosad, abamectin, and / or cyromazine; Coleoptera with reduced susceptibility to one or more compounds selected from group a2; Coleoptera with reduced susceptibility to one or more compounds selected from group a3; Coleoptera with reduced susceptibility to one or more compounds selected from group a4; Coleoptera with reduced susceptibility to one or more compounds selected from group a9; Coleoptera with reduced susceptibility to one or more compounds selected from group a17; Coleoptera with reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4; Chrysomelidae with reduced susceptibility to one or more compounds selected from group a2; Chrysomelidae with reduced susceptibility to one or more compounds selected from group a3; Chrysomelidae with reduced susceptibility to one or more compounds selected from group a4; Chrysomelidae with reduced susceptibility to one or more compounds selected from group a9;Chrysomelidae species having reduced susceptibility to one or more compounds selected from group a17; Chrysomelidae species having reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4; Rice leaf beetles having reduced susceptibility to one or more compounds selected from group a2; Rice leaf beetles having reduced susceptibility to one or more compounds selected from group a4; Rice leaf beetles having reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4; Diablotica species having reduced susceptibility to one or more compounds selected from group a2; Diablotica species having reduced susceptibility to one or more compounds selected from group a3; Diablotica species having reduced susceptibility to one or more compounds selected from group a4; Diablotica species having reduced susceptibility to one or more compounds selected from group a9; Diablotica species having reduced susceptibility to one or more compounds selected from group a17; Western corn rootworms having reduced susceptibility to one or more compounds selected from group a2; Western corn rootworms having reduced susceptibility to one or more compounds selected from group a3; Western corn rootworms having reduced susceptibility to one or more compounds selected from group a4; Western corn rootworms having reduced susceptibility to one or more compounds selected from group a9; Western corn rootworms having reduced susceptibility to one or more compounds selected from group a17; Southern corn rootworms having reduced susceptibility to one or more compounds selected from group a2; Southern corn rootworms having reduced susceptibility to one or more compounds selected from group a3; Southern corn rootworms having reduced susceptibility to one or more compounds selected from group a4; Southern corn rootworms having reduced susceptibility to one or more compounds selected from group a9; Southern corn rootworms having reduced susceptibility to one or more compounds selected from group a17; Northern corn rootworms having reduced susceptibility to one or more compounds selected from group a2; Northern corn rootworms having reduced susceptibility to one or more compounds selected from Group a3;Northern corn rootworms having reduced susceptibility to one or more compounds selected from group a4; Northern corn rootworms having reduced susceptibility to one or more compounds selected from group a9; Northern corn rootworms having reduced susceptibility to one or more compounds selected from group a17; Cucabit beetles having reduced susceptibility to one or more compounds selected from group a2; Cucabit beetles having reduced susceptibility to one or more compounds selected from group a3; Cucabit beetles having reduced susceptibility to one or more compounds selected from group a4; Cucabit beetles having reduced susceptibility to one or more compounds selected from group a9; Cucabit beetles having reduced susceptibility to one or more compounds selected from group a17; Colorado potato beetles having reduced susceptibility to one or more compounds selected from group a2; Colorado potato beetles having reduced susceptibility to one or more compounds selected from group a3; Colorado potato beetles having reduced susceptibility to one or more compounds selected from group a4; Colorado potato beetles having reduced susceptibility to one or more compounds selected from group a11; Colorado potato beetles having reduced susceptibility to one or more compounds selected from group a17; Striped flea beetles having reduced susceptibility to one or more compounds selected from group a3; Striped flea beetles having reduced susceptibility to one or more compounds selected from group a4; Striped flea beetles having reduced susceptibility to one or more compounds selected from group a17; Cabbage free beetles having reduced susceptibility to one or more compounds selected from group a3; Cabbage free beetles having reduced susceptibility to one or more compounds selected from group a4; Cabbage free beetles having reduced susceptibility to one or more compounds selected from group a17; Western black free beetles having reduced susceptibility to one or more compounds selected from group a3; Western black free beetles having reduced susceptibility to one or more compounds selected from group a4; Western black free beetles having reduced susceptibility to one or more compounds selected from group a17; a cabbage stem free beetle having reduced susceptibility to one or more compounds selected from group a3;Cabbage stem free beetles having reduced susceptibility to one or more compounds selected from group a4; Cabbage stem free beetles having reduced susceptibility to one or more compounds selected from group a17; Hop free beetles having reduced susceptibility to one or more compounds selected from group a3; Hop free beetles having reduced susceptibility to one or more compounds selected from group a4; Hop free beetles having reduced susceptibility to one or more compounds selected from group a17; Curculionidae having reduced susceptibility to one or more compounds selected from group a2; Curculionidae having reduced susceptibility to one or more compounds selected from group a4; Curculionidae having reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4; Rice water weevils having reduced susceptibility to one or more compounds selected from group a2; Rice water weevils having reduced susceptibility to one or more compounds selected from group a4; Rice water weevils having reduced susceptibility to one or more compounds selected from group a2 and one or more compounds selected from group a4; Elateridae having reduced susceptibility to one or more compounds selected from group a2; Elateridae having reduced susceptibility to one or more compounds selected from group a3; Elateridae having reduced susceptibility to one or more compounds selected from group a4; Okinawan sugar beetles having reduced susceptibility to one or more compounds selected from group a2; Okinawan sugar beetles having reduced susceptibility to one or more compounds selected from group a3; Okinawan sugar beetles having reduced susceptibility to one or more compounds selected from group a4; Brown rice weevils having reduced susceptibility to one or more compounds selected from group a2; Brown rice weevils having reduced susceptibility to one or more compounds selected from group a3; A rice brown rice click beetle having reduced susceptibility to one or more compounds selected from group a4; A rice brown rice click beetle having reduced susceptibility to one or more compounds selected from group a2; A rice brown rice click beetle having reduced susceptibility to one or more compounds selected from group a3; A rice brown rice click beetle having reduced susceptibility to one or more compounds selected from group a4;A species of the genus Elateria having reduced susceptibility to one or more compounds selected from group a2; A species of the genus Elateria having reduced susceptibility to one or more compounds selected from group a3; A species of the genus Elateria having reduced susceptibility to one or more compounds selected from group a4; A species of the genus Conoderus having reduced susceptibility to one or more compounds selected from group a2; A species of the genus Conoderus having reduced susceptibility to one or more compounds selected from group a3; A species of the genus Conoderus having reduced susceptibility to one or more compounds selected from group a4; A species of the genus Ctenicella having reduced susceptibility to one or more compounds selected from group a2; A species of the genus Ctenicella having reduced susceptibility to one or more compounds selected from group a3; A species of the genus Ctenicella having reduced susceptibility to one or more compounds selected from group a4; A species of the genus Limonius having reduced susceptibility to one or more compounds selected from group a2; A species of the genus Limonius having reduced susceptibility to one or more compounds selected from group a3; Limonius species having reduced susceptibility to one or more compounds selected from group a4; Aeolus species having reduced susceptibility to one or more compounds selected from group a2; Aeolus species having reduced susceptibility to one or more compounds selected from group a3; Aeolus species having reduced susceptibility to one or more compounds selected from group a4; Cabbage stem free beetles having reduced susceptibility to lambda-cyhalothrin; Colorado potato beetles having reduced susceptibility to carbosulfan, carbofuran, phosalone, chlorpyrifos, azinphos-methyl, cyhalothrin, lambda-cyhalothrin, deltamethrin, permethrin, imidacloprid, dinotefuran, clothianidin, thiacloprid, thiamethoxam, and / or nitenpyram; Blossom beetles with reduced susceptibility to phosalone, lambda-cyhalothrin, cypermethrin, alphacypermethrin, zetacypermethrin, bifenthrin, beta-cyfluthrin, deltamethrin, esfenvalerate, tau-fluvalinate, and / or acetamiprid; Acari with reduced susceptibility to one or more compounds selected from group a2; Acari with reduced susceptibility to one or more compounds selected from group a3; Acari with reduced susceptibility to one or more compounds selected from group a4;Acari having reduced susceptibility to one or more compounds selected from group a9; Acari having reduced susceptibility to one or more compounds selected from group a17; Twospotted Spider Mites having reduced susceptibility to one or more compounds selected from group a19, bifenthrin, abamectin, milbemectin, acequinocyl and / or bifenazate; Red Mite (Panthera ulmi) having reduced susceptibility to fenpropathrin, spirodiclofen, clofentezine, hexythiazox, pyridaben, and / or fenpyroximate; Bed bugs having reduced susceptibility to one or more compounds selected from group a1; Bed bugs having reduced susceptibility to one or more compounds selected from group a2; Bed bugs having reduced susceptibility to one or more compounds selected from group a3; Bed bugs having reduced susceptibility to one or more compounds selected from group a4; Bed bugs having reduced susceptibility to one or more compounds selected from group a5; bed bugs having reduced susceptibility to one or more compounds selected from Group a10; bed bugs having reduced susceptibility to bendiocarb, diazinon, dichlorvos, fenitrothion, fenobucarb, malathion, propoxur, dieldrin, fipronil, allethrin, bifenthrin, cyfluthrin, beta-cyfluthrin, lambda-cyhalothrin, cypermethrin, alphacypermethrin, deltamethrin, esfenvalerate, etofenprox, permethrin, fenothrin, pyrethrins, tetramethrin, DDT, acetamiprid, dinotefuran, imidacloprid, thiamethoxam, spinosad, and / or chlorfenapyr; nettite body bugs having reduced susceptibility to one or more compounds selected from Group a1; nettite body bugs having reduced susceptibility to one or more compounds selected from Group a2; Nettle bugs with reduced susceptibility to one or more compounds selected from group a3; Nettle bugs with reduced susceptibility to one or more compounds selected from group a4; Nettle bugs with reduced susceptibility to one or more compounds selected from group a10;Nettle body flies with reduced susceptibility to bendiocarb, diazinon, fenitrothion, fenobucarb, malathion, propoxur, dieldrin, fipronil, allethrin, bifenthrin, cyfluthrin, lambda-cyhalothrin, cypermethrin, alphacypermethrin, deltamethrin, esfenvalerate, etofenprox, permethrin, DDT, imidacloprid, and / or chlorfenapyr; houseflies with reduced susceptibility to one or more compounds selected from group a1; houseflies with reduced susceptibility to one or more compounds selected from group a2; houseflies with reduced susceptibility to one or more compounds selected from group a3; houseflies with reduced susceptibility to one or more compounds selected from group a4; houseflies with reduced susceptibility to one or more compounds selected from group a5; houseflies with reduced susceptibility to one or more compounds selected from group a6; Houseflies with reduced susceptibility to one or more compounds selected from group a7; houseflies with reduced susceptibility to one or more compounds selected from group a11; houseflies with reduced susceptibility to one or more compounds selected from group a12; houseflies with reduced susceptibility to one or more compounds selected from group a13; houseflies with reduced susceptibility to one or more compounds selected from group a14; houseflies with reduced susceptibility to one or more compounds selected from group a15;Azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, diazinon, dichlorvos, dimethoate, fenchlorphos, fenitrothion, methomyl, methoxychlor, naled, parathion-methyl, phoxim, profenofos, propoxur, tetrachlorvinphos, triazophos, trichlorfon, dieldrin, endosulfan, fipronil, bifenthrin, cyfluthrin, beta-cyfluthrin, lambda-cyhalothrin, cypermethrin, beta- houseflies with reduced susceptibility to tacipermethrin, cyphenothrin, deltamethrin, esfenvalerate, fenothrin, pyrethrins, resmethrin, DDT, acetamiprid, dinotefuran, imidacloprid, nitenpyram, thiamethoxam, spinosad, abamectin, emamectin benzoate, methoprene, pyriproxyfen, cartap, diflubenzuron, lufenuron, triflumuron, cyromazine, methoxyfenozide, and / or indoxacarb; Simulium damnosum having reduced susceptibility to one or more compounds selected from group a1; Simulium damnosum having reduced susceptibility to one or more compounds selected from group a3; Culex pipiens mosquito having reduced susceptibility to one or more compounds selected from group a2; Culex pipiens mosquito having reduced susceptibility to one or more compounds selected from group a3; Culex pipiens mosquito having reduced susceptibility to bifenthrin, beta-cyfluthrin, lambda-cyhalothrin, cypermethrin, deltamethrin, permethrin, and / or resmethrin; Culex pipiens molestus having reduced susceptibility to one or more compounds selected from group a3; Culex pipiens molestus having reduced susceptibility to deltamethrin, etofenprox, permethrin, and / or fenothrin; Culex quinquefasciatus having reduced susceptibility to one or more compounds selected from group a1; Culex quinquefasciatus having reduced susceptibility to one or more compounds selected from group a3; quinquefasciatus mosquitoes with reduced susceptibility to temephos, bifenthrin, beta-cyfluthrin, lambda-cyhalothrin, cypermethrin, deltamethrin, permethrin, and / or resmethrin; Aedes aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a1;aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a3; Aedes aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a7; Aedes aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a9; Aedes aegypti mosquitoes with reduced susceptibility to chlorpyrifos, dichlorvos, fenitrothion, fenthion, malathion, pirimiphos-methyl, propoxur, temephos, allethrin, bifenthrin, cyfluthrin, lambda-cyhalothrin, cypermethrin, alphacypermethrin, deltamethrin, etofenprox, permethrin, fenothrin, DDT, and / or methoprene; Aedes aegypti mosquitoes with reduced susceptibility to the delta-endotoxins Cry4A and Cry4B; Anopheles gambiae mosquitoes with reduced susceptibility to one or more compounds selected from group a1; Anopheles gambiae mosquitoes with reduced susceptibility to one or more compounds selected from group a2; Anopheles gambiae mosquitoes with reduced susceptibility to one or more compounds selected from group a3; Anopheles gambiae mosquitoes with reduced susceptibility to bendiocarb, fenitrothion, pirimiphos-methyl, dieldrin, lambda-cyhalothrin, deltamethrin, permethrin, and / or DDT; Anopheles coluzzii with reduced susceptibility to one or more compounds selected from group a1; Anopheles coluzzii with reduced susceptibility to one or more compounds selected from group a2; Anopheles coluzzii with reduced susceptibility to one or more compounds selected from group a3; Anopheles coluzzii with reduced susceptibility to bendiocarb, fenitrothion, dieldrin, lambda-cyhalothrin, deltamethrin, permethrin, and / or DDT; Anopheles arabiensis with reduced susceptibility to one or more compounds selected from group a1; Anopheles coluzzii with reduced susceptibility to one or more compounds selected from group a2. Anopheles arabiensis having reduced susceptibility to one or more compounds selected from group a3;Anopheles arabiensis with reduced susceptibility to bendiocarb, malathion, dieldrin, lambda-cyhalothrin, deltamethrin, permethrin, and / or DDT; Anopheles funestus with reduced susceptibility to one or more compounds selected from group a2; Anopheles funestus with reduced susceptibility to one or more compounds selected from group a3; Anopheles funestus with reduced susceptibility to dieldrin, lambda-cyhalothrin, deltamethrin, permethrin, and / or DDT; Red flour beetles with reduced susceptibility to one or more compounds selected from group a1; Red flour beetles with reduced susceptibility to one or more compounds selected from group a3; Red flour beetles with reduced susceptibility to one or more compounds selected from group a5; Red flour beetles with reduced susceptibility to one or more compounds selected from group a21; Flour beetles having reduced susceptibility to carbaryl, chlorpyrifos, chlorpyrifos-methyl, cyanophos, diazinon, dichlorvos, fenitrothion, malathion, phoxim, pirimiphos-methyl, promecarb, propoxur, temephos, tetrachlorvinphos, bioresmethrin, cyfluthrin, cyhalothrin, cypermethrin, deltamethrin, permethrin, fenothrin, pyrethrins, DDT, spinosad, and / or phosphine; German cockroaches having reduced susceptibility to one or more compounds selected from group a1; German cockroaches having reduced susceptibility to one or more compounds selected from group a2; German cockroaches having reduced susceptibility to one or more compounds selected from group a3; German cockroaches having reduced susceptibility to one or more compounds selected from group a4; German cockroaches having reduced susceptibility to one or more compounds selected from group a6; German cockroaches with reduced susceptibility to chlorpyrifos, malathion, propoxur, fipronil, beta-cyfluthrin, cypermethrin, deltamethrin, permethrin, pyrethrins, DDT, imidacloprid, and / or abamectin; cat fleas with reduced susceptibility to one or more compounds selected from group a1;Cat fleas with reduced susceptibility to one or more compounds selected from group a2; Cat fleas with reduced susceptibility to one or more compounds selected from group a3; Cat fleas with reduced susceptibility to one or more compounds selected from group a4; Cat fleas with reduced susceptibility to one or more compounds selected from group a5; Cat fleas with reduced susceptibility to bendiocarb, carbaryl, chlorfenvinphos, chlorpyrifos, diazinon, fenthion, isofenphos, propetamphos, propoxur, malathion, fipronil, cyfluthrin, cypermethrin, fluvalinate, permethrin, pyrethrins, imidacloprid, and / or spinosad; American dog ticks with reduced susceptibility to one or more compounds selected from group a3; American dog ticks with reduced susceptibility to DDT; Bovine ticks with reduced susceptibility to one or more compounds selected from group a1; Bovine ticks with reduced susceptibility to one or more compounds selected from group a2; Bovine ticks with reduced susceptibility to one or more compounds selected from group a3; Bovine ticks with reduced susceptibility to one or more compounds selected from group a6; Bovine ticks with reduced susceptibility to one or more compounds selected from group a20; Bovine ticks with reduced susceptibility to carbaryl, chlorpyrifos, coumaphos, fipronil, pyriprole, cypermethrin, deltamethrin, flumethrin, permethrin, ivermectin, and / or amitraz; Rhipicephalus sanguineus with reduced susceptibility to one or more compounds selected from group a1; Rhipicephalus sanguineus with reduced susceptibility to one or more compounds selected from group a3; Rhipicephalus sanguineus with reduced susceptibility to one or more compounds selected from group a20; Brown dog ticks with reduced susceptibility to permethrin and / or amitraz;

[0046] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes whose susceptibility has been reduced by substituting one or more amino acids in the target protein include the following. cotton aphid having an R81T amino acid substitution in the beta subunit of the nicotinic acetylcholine receptor; green peach aphid having an R81T amino acid substitution in the beta subunit of the nicotinic acetylcholine receptor; diamondback moth having a G4946E amino acid substitution in the ryanodine receptor; diamondback moth having an F1845Y or V1848I amino acid substitution in the sodium channel; whitebacked planthopper having an A2'N amino acid substitution in the GABA-gated chloride channel; cotton aphid having S431F and / or A302S amino acid substitution in acetylcholinesterase; sweet potato whitefly having L925I and / or T929V amino acid substitution in the voltage-gated sodium channel; green peach aphid having S431F amino acid substitution in acetylcholinesterase; green peach aphid having L1014F, M918T, and / or TL932F amino acid substitutions in the voltage-gated sodium channel; green peach aphid having A302S and / or A302G amino acid substitutions in a GABA-gated chloride channel; western flower thrips having L1014F and / or M918T amino acid substitutions in a voltage-gated sodium channel; western flower thrips having G275E amino acid substitutions in the α6 subunit of the nicotinic acetylcholine receptor; corn earworm having L1029H, V421M, V421A, V421G and / or I951V amino acid substitutions in a voltage-gated sodium channel; tobacco budworm having L1029H, D1561V, E1565G and / or V421M amino acid substitutions in a voltage-gated sodium channel; Colorado potato beetle having R30K, S291G and / or I392T amino acid substitutions in acetylcholinesterase; The Colorado potato beetle has an amino acid substitution of L1014F in the voltage-gated sodium channel; the white-backed planthopper has an amino acid substitution of S298P in acetylcholinesterase type 1; the two-spotted spider mite has an amino acid substitution of G323D in the GluCl1 subunit of the glutamate receptor;Twospotted spider mite having a G326E amino acid substitution in the GluCl3 subunit of the glutamate receptor; Onion thrips having M918T, M918L, T929I, V1010A, and / or L1014F amino acid substitutions in the voltage-gated sodium channel; Trialeurodes vaporariorum having L925I and / or T929I amino acid substitutions in the voltage-gated sodium channel; Tuta absoluta having G4903V, G4903E, I4746T, and / or I4746M amino acid substitutions in the ryanodine receptor; Brown planthopper having an A301S amino acid substitution in the GABA-gated chloride channel; Brown planthopper having a Y151S amino acid substitution in the α1 and α3 subunits of the nicotinic acetylcholine receptor; European corn borer having an L1014F amino acid substitution in the voltage-gated sodium channel; the European red mite having an F1538I amino acid substitution in a voltage-gated sodium channel; the cabbage stem beetle having an L1014F amino acid substitution in a voltage-gated sodium channel; the English grain aphid having an L1014F amino acid substitution in a voltage-gated sodium channel; the diamondback moth having an A282S, A282G, and / or A302S amino acid substitution in a GABA-gated chloride channel; the diamondback moth having an M918I, T929I, and / or L1014F amino acid substitution in a voltage-gated sodium channel; the bed bug having V419L, L925I, and / or I936F amino acid substitution in the alpha subunit of a voltage-gated sodium channel; a housefly having an amino acid substitution of V180L, V260L, G262A, G262V, G342A, G342V, G365A, F327Y, F407Y, and / or G445A in acetylcholinesterase; a housefly having an amino acid substitution of M918T, L1014F, and / or L1014H in the alpha subunit of a voltage-gated sodium channel; a housefly having an amino acid substitution of A302S in a GABA-gated chloride channel; a Culex pipiens mosquito having an amino acid substitution of L1014F and / or L1014S in a voltage-gated sodium channel; a Culex pipiens mosquito having an amino acid substitution of A302S in a GABA-gated chloride channel;Culex quinquefasciatus having an amino acid substitution of L1014F and / or L1014S in a voltage-gated sodium channel; Culex quinquefasciatus having an amino acid substitution of L1014F and / or L1014S in a voltage-gated sodium channel; Culex quinquefasciatus having an amino acid substitution of G119S in acetylcholinesterase; Aedes aegypti having an amino acid substitution of V410L, G923V, L982W, S989P, I1011M, I1011V, V1016I, V1016G, T1520I, F1534C, and / or D1763Y in a voltage-gated sodium channel; Anopheles gambiae having an amino acid substitution of L1014S and / or N1575Y in a voltage-gated sodium channel; Anopheles gambiae having an amino acid substitution of G119S in acetylcholinesterase; Anopheles coluzzii having an amino acid substitution of L1014F and / or N1575Y in a voltage-gated sodium channel; Anopheles arabiensis having an amino acid substitution of L1014F in a voltage-gated sodium channel; Anopheles funestus having an amino acid substitution of A296S and / or V327I in a GABA-gated chloride channel; Tribolium castaneum having an amino acid substitution of A302S in a GABA-gated chloride channel; Blattella germanica having amino acid substitutions of D58G, E434K, C764R, L933F, and / or P1880L in a voltage-gated sodium channel; Blattella germanica having an amino acid substitution of A302S in a GABA-gated chloride channel; Cat flea having an amino acid substitution of T929V and / or L1014F in a voltage-gated sodium channel; Cat flea having an amino acid substitution of A302S in a GABA-gated chloride channel; Boophilus ticks with C190A and / or F1550I amino acid substitutions in the voltage-gated sodium channel;

[0047] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes that have reduced susceptibility due to a decrease in target proteins include the following: houseflies with reduced expression of the α2 subunit of the nicotinic acetylcholine receptor;

[0048] Factors that increase metabolic enzyme activity include, for example, overexpression of metabolic enzyme genes (also known as quantitative mutations) and improved affinity for drugs due to amino acid substitutions in metabolic enzymes (also known as qualitative mutations). One or more of these factors that increase metabolic enzyme activity may be present.

[0049] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes in which metabolic enzyme activity has increased due to overexpression of metabolic enzyme genes include the following. The brown planthopper overexpressed CYP6ER1 (a type of cytochrome P450 gene); Amrasca biguttula biguttula overexpressed glutathione-S-transferase gene; the cotton aphid overexpressed cytochrome P450 monooxygenase gene; the Bemisia tabaci overexpressed CYP6CM1 (a type of cytochrome P450-dependent monooxygenase gene); the Bemisia tabaci overexpressed cytochrome P450-dependent monooxygenase gene; the rice stem borer overexpressed carboxylesterase gene and / or microsomal-O-demethylase gene; the codling moth overexpressed glutathione-S-transferase gene and / or cytochrome P450 monooxygenase gene; three aminopeptidases Sugarcane borer with reduced expression of N genes (DsAPN1, DsAPN2, and DsAPN3) and / or DsCAD1 (a type of cadherin gene); bean leafminer with overexpression of cytochrome P450 genes; blossom beetle with overexpression of cytochrome P450 genes; green peach aphid with overexpression of CYP6CY3 (a type of cytochrome P450 gene); green peach aphid with overexpression of E4 gene, a type of carboxylesterase, and / or FE4 gene, a type of carboxylesterase; lettuce long-spin aphid with overexpression of esterase gene; lettuce long-spin aphid with overexpression of glutathione S-transferase gene; brown stink bug with overexpression of esterase gene;Brown stink bug in which the gene for EST-2, a type of cholinesterase, and / or the gene for EST-4, a type of cholinesterase, is overexpressed; Western flower thrips in which an esterase gene is overexpressed; Western flower thrips in which a cytochrome P450 monooxygenase gene is overexpressed; Western flower thrips in which a glutathione S-transferases gene is overexpressed; Helicoverpa armigera in which CYP337B3 (a type of cytochrome P450 gene) is expressed; Helicoverpa armigera in which a cytochrome P450 monooxygenases gene is overexpressed; Helicoverpa armigera in which a glutathione S-transferases gene is overexpressed; Helicoverpa armigera in which an esterase gene is overexpressed; Helicoverpa armigera in which a glutathione-S-transferase ... an esterase gene is overexpressed; Helicoverpa armigera in which an esterase gene is overexpressed; Helicoverpa armigera in which an esterase gene is overexpressed; cytochrome Helicoverpa distichum with overexpression of P450 genes; Colorado potato beetle with overexpression of glutathione-S-transferase genes; Colorado potato beetle with overexpression of esterase genes; Colorado potato beetle with overexpression of cytochrome P450 genes; Two-spotted spider mite with overexpression of TuGSTd14 (a type of glutathione-S-transferase gene); Tribolium castaneum with overexpression of CYP6CM1 (a type of cytochrome P450 gene) in greenhouse whitefly; Red flour beetle with overexpression of cytochrome P450 genes; Brown planthopper with reduced expression of CYP6AY1 (a type of cytochrome P450 gene); Brown planthopper with overexpression of carboxylesterase genes; Brown planthopper with overexpression of Nl-EST1, a type of carboxylesterase; The brown planthopper overexpresses CYP6ER1, CYP6AY1, and / or CYP6FU1 (a type of cytochrome P450 gene); the European corn borer overexpresses the cytochrome P450 monooxygenase gene;European corn borer overexpressing a glutathione-S-transferase gene; European red mite overexpressing a cytochrome P450-dependent monooxygenase gene; Cabbage stem free beetle overexpressing a cytochrome P450 gene; Bed bugs overexpressing CYP397A1, CYP398A1, CYP6DN1, CYP4CM1, and / or CYP400A1 (all cytochrome P450 genes); Bed bugs overexpressing CE3959 and / or CE21331 (all carboxylesterase genes); Bed bugs overexpressing S1 (a glutathione-S-transferase gene); houseflies overexpressing CYP6A1, CYP6A5v1, CYP6A5v2, CYP6A36, CYP6A40, CYP6D1, CYP6D1v1, CYP6D3, CYP6D8, CYP6G2, and / or CYP6G4 (all types of cytochrome P450 genes); Culex quinquefasciatus overexpressing CYP9M10, CYP6AA7, and / or CYP4H34 (all types of cytochrome P450 genes); Aedes aegypti overexpressing an esterase gene; Aedes aegypti overexpressing a glutathione-S-transferase gene; Aedes aegypti overexpressing CYP4D24, CYP6BB2, CYP6F3, CYP6M11, CYP6N12, and / or CYP9M6 (all types of cytochrome P450 genes); aegypti mosquitoes with overexpression of a carboxylesterase gene; Anopheles gambiae mosquitoes with overexpression of CYP4P16, CYP4P17, CYP6P3, CYP6Z1, CYP12F1, and / or CYP325A3 (all of which are cytochrome P450 genes); Anopheles gambiae mosquitoes with overexpression of GSTE2 (a type of glutathione-S-transferase gene); Anopheles gambiae mosquitoes with overexpression of PX13A and / or PX13B (all of which are peroxidase genes); Anopheles gambiae mosquitoes with overexpression of an esterase gene;Anopheles arabiensis with overexpression of CYP6P4 (a type of cytochrome P450 gene); Anopheles arabiensis with overexpression of a carboxylesterase gene; Anopheles arabiensis with overexpression of a beta-esterase gene; Anopheles funestus with overexpression of CYP6P4 and / or CYP6P9 (both cytochrome P450 genes); Tribolium castaneum with overexpression of CYP6BQ9 (a type of cytochrome P450 gene); Tribolium castaneum with overexpression of a glutathione-S-transferase gene; Tribolium castaneum with overexpression of Epsilon (a type of glutathione-S-transferase gene); German cockroach with overexpression of CYP4G19 (a type of cytochrome P450 gene);

[0050] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes in which metabolic enzyme activity has been increased due to improved drug affinity through amino acid substitution in the metabolic enzyme include: Nilaparvata lugens having CYP6ER1vA (a mutant type of CYP6ER1) with amino acid substitutions of T318S, A375δ, and A376G; Nilaparvata lugens having CYP6ER1vB (a mutant type of CYP6ER1) with amino acid substitutions of T318S and A377δ; Musca domestica having carboxyesterase with amino acid substitutions of W251L and / or W251S; and Tribolium castaneum having dihydrolipoamide dehydrogenase with amino acid substitutions of P45S and / or G131S.

[0051] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes that have multiple factors that increase the activity of metabolic enzymes include the brown planthopper, which has reduced sensitivity to imidacloprid due to the presence of CYP6ER1vA and CYP6ER1vB in addition to overexpression of CYP6ER1.

[0052] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes that have reduced susceptibility due to reduced skin permeability include the following: Helicoverpa armigera, which has reduced susceptibility to pyrethroids (e.g., cypermethrin, esfenvalerate, etc.) due to reduced cuticular penetration of the drug; and bedbugs, which have reduced susceptibility to pyrethroids (e.g., beta-cyfluthrin) due to overexpression of C2, C10, and / or C13 (all of which are putative cuticular protein genes).

[0053] Examples of harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes that have reduced susceptibility due to enhanced excretion function by membrane transporters include the following: bedbugs in which the ABC transporter genes Abc8, Abc9, Abc10, and / or Abc11 are overexpressed.

[0054] Examples of Aphididae pests include the cotton aphid, the green peach aphid, and the lettuce aphid. Examples of Planthoppers include the brown planthopper, the white-backed planthopper, and the small brown planthopper. Examples of Aleyrodidae pests include the tobacco whitefly and the greenhouse whitefly.

[0055] The method for controlling arthropod pests of the present invention is carried out by applying an effective amount of the present compound, the compound of the present invention, or Composition A directly to the arthropod pests and / or to the habitat of the arthropod pests (plants, soil, houses, animals, etc.). Examples of the method for controlling arthropod pests of the present invention include foliage treatment, soil treatment, root treatment, shower treatment, fumigation treatment, water surface treatment, and seed treatment.

[0056] The present compound, the compound of the present invention, or Composition A is typically formulated into an aqueous suspension, oil suspension, oil concentrate, emulsifiable concentrate, emulsion, microemulsion, microcapsule, wettable powder, water dispersible granule, dust, granule, tablet, aerosol, resin formulation, or the like by mixing an inactivated carrier such as a solid carrier, liquid carrier, or gaseous carrier with a surfactant, and optionally adding formulation adjuvants such as binders, dispersants, and stabilizers. In addition to these formulations, the present compound, the compound of the present invention, or Composition A can also be formulated into dosage forms described in the Manual on development and use of FAO and WHO Specifications for pesticides, FAO Plant Production and Protection Papers-271 to 276, prepared by the FAO / WHO Joint Meeting on Pesticide Specifications, 2016, ISSN:0259-2517. These formulations typically contain 0.0001 to 99% by weight of the present compound, the compound of the present invention, or Composition A.

[0057] Examples of solid carriers include clay (pyrophyllite clay, kaolin clay, etc.), talc, calcium carbonate, diatomaceous earth, zeolite, bentonite, acid clay, attapulgite, white carbon, ammonium sulfate, vermiculite, perlite, pumice, silica sand, fine powder and granular chemical fertilizers (ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride, etc.), and resins (polypropylene, polyester, polyurethane, polyamide, polyvinyl chloride, etc.).

[0058] Examples of liquid carriers include water, alcohols (ethanol, cyclohexanol, benzyl alcohol, propylene glycol, polyethylene glycol, etc.), ketones (acetone, cyclohexanone, etc.), aromatic hydrocarbons (xylene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, etc.), esters (ethyl acetate, methyl oleate, propylene carbonate, etc.), nitriles (acetonitrile, etc.), ethers (ethylene glycol dimethyl ether, etc.), amides (N,N-dimethylformamide, N,N-dimethyloctanamide, etc.), sulfoxides (dimethyl sulfoxide, etc.), lactams (N-methylpyrrolidone, N-octylpyrrolidone, etc.), fatty acids (oleic acid, etc.), and vegetable oils (soybean oil, etc.).

[0059] Examples of gaseous carriers include fluorocarbons, butane gas, LPG (liquefied petroleum gas), dimethyl ether, nitrogen, and carbon dioxide gas.

[0060] Examples of surfactants include nonionic surfactants (polyoxyethylene alkyl ethers, polyoxyethylene alkylaryl ethers, polyethylene glycol fatty acid esters, etc.) and anionic surfactants (alkyl sulfonates, alkylaryl sulfonates, alkyl sulfates, etc.). Specific examples include Nimbus (registered trademark), Assist (registered trademark), Aureo (registered trademark), Iharol (registered trademark), Silwet L-77 (registered trademark), BreakThru (registered trademark), Sundance II (registered trademark), Induce (registered trademark), Penetrator (registered trademark), AgriDex (registered trademark), Lutensol A8 (registered trademark), NP-7 (registered trademark), Triton (registered trademark), Nufilm (registered trademark), Emulgator NP7 (registered trademark), Emulad (registered trademark), TRITON X 45 (registered trademark), AGRAL 90 (registered trademark), AGROTIN (registered trademark), ARPON (registered trademark), EnSpray N (registered trademark), and BANOLE (registered trademark).

[0061] Other formulation adjuvants include binders, dispersants, colorants, stabilizers, etc., and specific examples include polysaccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), acid isopropyl phosphate, and dibutylhydroxytoluene.

[0062] In the present invention, the plant includes the whole plant, stems and leaves, flowers, spikes, fruits, trunks, branches, crowns, seeds, vegetative reproductive organs, and seedlings.

[0063] Vegetative reproductive organs refer to plant roots, stems, leaves, and other parts that can grow when separated from the main body and placed in soil. Examples of vegetative reproductive organs include tuberous roots, creeping roots, bulbs, corms (or solid bulbs), tubers, rhizomes, stolons, rhizophores, cane cuttings, propagules, and vine cuttings. Stolons are sometimes called runners, and propagules are also called bulbils and are divided into broad buds and bulbils. Vines refer to shoots (a collective term for leaves and stems) of plants such as sweet potatoes and Japanese yams. Bulbs, corms, tubers, rhizomes, stem fragments, rhizophores, and tuberous roots are collectively called bulbils. Potato cultivation begins by planting tubers in the soil, and the tubers used are generally called seed potatoes.

[0064] Examples of methods for controlling harmful arthropods by applying an effective amount of the present compound, the compound of the present invention, or Composition A to soil include methods in which an effective amount of the present compound, the compound of the present invention, or Composition A is applied to soil before or after planting a plant. More specifically, for example, planting hole treatment (spraying in planting holes, mixing in planting hole treatment soil), plant base treatment (spraying in planting holes, mixing in plant base soil, plant base irrigation, plant base treatment in the latter half of the seedling raising period), planting furrow treatment (spraying in planting furrows, mixing in planting furrow soil), row treatment (row spraying, row soil mixing, row spraying in the growing season), row treatment at sowing (row spraying at sowing, mixing in row soil at sowing), overall treatment (overall soil spraying, overall soil mixing), side row treatment, water surface treatment (water surface application, water surface application after flooding), other soil spray treatments (foliar spraying of granules during the growing season, spraying under the crown or around the main trunk, soil surface spraying, soil surface mixing, seeding hole spraying, furrow surface spraying, spraying between plants), and others. Other irrigation treatments include soil irrigation, seedling irrigation, chemical injection treatment, ground level irrigation, chemical drip irrigation, chemigation), seedling tray treatments (seedling tray spraying, seedling tray irrigation, seedling tray flooding), seedling tray treatments (seedling tray spraying, seedling tray irrigation, seedling tray flooding), seedling bed treatments (seedling bed spraying, seedling bed irrigation, water seedling bed spraying, seedling immersion), bed soil mixing treatments (bed soil mixing, bed soil mixing before sowing, spraying before soil covering at sowing, spraying after soil covering at sowing, covering soil mixing), and other treatments (hilling soil mixing, plowing in, topsoil mixing, rain-drop soil mixing, planting position treatment, granular inflorescence spraying, paste fertilizer mixing).

[0065] Seed treatments include, for example, treatment of seeds or vegetative reproductive organs with the present compound, the compound of the present invention, or Composition A. More specifically, examples include spray treatments in which a suspension of the present compound, the compound of the present invention, or Composition A is sprayed onto the surface of seeds or vegetative reproductive organs; smear treatments in which the present compound, the compound of the present invention, or Composition A is applied to seeds or vegetative reproductive organs; immersion treatments in which seeds are immersed in a solution of the present compound, the compound of the present invention, or Composition A for a certain period of time; and methods of coating seeds or vegetative reproductive organs with a carrier containing the present compound, the compound of the present invention, or Composition A (film coating treatment, pellet coating treatment, etc.). Seed potatoes are particularly examples of the above-mentioned vegetative reproductive organs. When applying Composition A to seeds or vegetative reproductive organs, Composition A can be applied to the seeds or vegetative reproductive organs as a single formulation, or multiple different formulations of Composition A can be applied to the seeds or vegetative reproductive organs in separate applications. Examples of the method of treating seeds or vegetative reproductive organs with multiple different formulations of Composition A include a method of treating seeds or vegetative reproductive organs with a formulation containing only the present compound or the compound of the present invention as an active ingredient, air-drying the seeds or vegetative reproductive organs, and then treating with a formulation containing the present component; and a method of treating seeds or vegetative reproductive organs with a formulation containing the present compound or the compound of the present invention and this component as active ingredients, air-drying the seeds or vegetative reproductive organs, and then treating with a formulation containing a component other than the present component that has already been treated. In the present invention, seeds or vegetative reproductive organs carrying the present compound, the compound of the present invention, or Composition A refer to seeds or vegetative reproductive organs in a state in which the present compound, the compound of the present invention, or Composition A is attached to the surface of the seeds or vegetative reproductive organs. The seeds or vegetative reproductive organs carrying the present compound, the compound of the present invention, or Composition A may have materials other than the present compound, the compound of the present invention, or Composition A attached to them before or after the attachment of the present compound, the compound of the present invention, or Composition A to the seeds or vegetative reproductive organs. Furthermore, when Composition A is attached to the surface of the seeds or vegetative reproductive organs in the form of a layer, the layer may consist of one layer or multiple layers. Furthermore, when it is composed of multiple layers, each layer contains one or more active ingredients, or it consists of a layer containing one or more active ingredients and a layer not containing any active ingredients.Seeds or vegetative reproductive organs carrying the present compound or the compound of the present invention or Composition A can be obtained, for example, by applying a formulation containing the present compound or the compound of the present invention or Composition A to seeds or vegetative reproductive organs by the seed treatment method described above.

[0066] When the present compound, the compound of the present invention, or Composition A is used for controlling harmful arthropods in the agricultural field, the application amount is 10,000 m 2 The amount of the present compound or the compound of the present invention applied per kg of seed or vegetative reproductive organ is usually 1 to 10,000 g. When treating seeds or vegetative reproductive organs, the amount of the present compound or the compound of the present invention applied per kg of seed or vegetative reproductive organ is usually in the range of 0.001 to 100 g. When the present compound, the compound of the present invention or Composition A is formulated as an emulsifiable concentrate, wettable powder, flowable concentrate or the like, it is usually applied after being diluted with water to an active ingredient concentration of 0.01 to 10,000 ppm, and granules, dusts and the like are usually applied as is.

[0067] Alternatively, the resin preparation can be processed into a sheet or string shape and wrapped around the crop, stretched around the crop, or spread on the soil around the base of the plant.

[0068] When the present compound, the compound of the present invention, or Composition A is used to control harmful arthropods living in houses, the application rate is 1 / 2 times the treatment area of ​​1 m when applying to a surface. 2 The amount of the present compound or the compound of the present invention per 1 m of treatment space is usually 0.01 to 1000 mg. 3 When the present compound, the compound of the present invention or Composition A is formulated as an emulsifiable concentrate, wettable powder, flowable concentrate or the like, it is usually applied after diluting with water so that the active ingredient concentration becomes 0.1 to 10,000 ppm, whereas oil solutions, aerosols, fumigants, poison baits and the like are applied as they are.

[0069] When the present compound, the compound of the present invention, or Composition A is used to control ectoparasites in livestock such as cattle, horses, pigs, sheep, goats, and chickens, or small animals such as dogs, cats, rats, and mice, it can be administered to animals by methods known in veterinary medicine. Specific methods of administration include, for example, administration by tablet, incorporation into feed, suppository, or injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) for systemic control, and administration by methods such as spraying an oil or aqueous liquid, pour-on application, spot-on application, washing the animal with a shampoo formulation, or attaching a resin formulation to the animal as a collar or ear tag. When administered to animals, the amount of the present compound, the compound of the present invention, or Composition A is usually in the range of 0.1 to 1000 mg per kg of the animal's body weight.

[0070] The present compound, the compound of the present invention or Composition A can be used as an agent for controlling harmful arthropods in agricultural lands such as fields, paddy fields, lawns, orchards, etc. Examples of plants include the following.

[0071] Corn (horse-tooth, hard grain, soft grain, explosive, glutinous, sweet, field corn), rice (long grain, short grain, medium grain, japonica, tropical japonica, indica, javanica, paddy rice, upland rice, floating rice, direct-seeded rice, transplanted rice, glutinous rice), wheat (bread wheat (hard, soft, medium, red wheat, white wheat), durum wheat, spelt wheat, club wheat, each winter wheat type, spring wheat type), barley (two-row barley (= beer barley), six-row barley, naked barley, waxy barley, each winter barley type, spring barley type), rye (winter rye type, spring rye type), triticale (winter triticale type, spring triticale type), oats (winter oat type, spring oat type), sorghum, cotton (upland type, pima type), soybean (fully harvested seed varieties, edamame varieties, green-harvested varieties, indeterminate, determinate, semi-determinate types), peanuts, buckwheat, sugar beet (sugar processing, animal feed, root vegetable, leafy vegetable, fuel), rapeseed (winter rapeseed type, spring rapeseed type), canola (winter canola type, spring canola type), sunflower (oil extraction, food, ornamental), sugarcane, tobacco, tea plant, mulberry, solanaceous vegetables (eggplant, tomato, bell pepper, chili pepper, jalapeno Potatoes, etc.), Cucurbitaceae vegetables (cucumbers, pumpkins, zucchini, watermelons, melons, etc.), Cruciferous vegetables (radishes, turnips, horseradish, kohlrabi, Chinese cabbage, cabbage, mustard greens, broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, chrysanthemums, artichokes, lettuce, etc.), Liliaceae vegetables (leeks, onions, garlic, asparagus, etc.), Umbelliferae vegetables (carrots, parsley, celery, parsley, etc.), Chenopodiaceae vegetables (spinach, Swiss chard, etc.), Lamiaceae vegetables (perilla, mint, basil, etc.), strawberries, sweet potatoes, yams, taro, Pome fruits (apples, European pears, Japanese pears, Chinese pears, quince, quince, etc.), stone fruits (peaches, plums, nectarines, plums, cherries, apricots, prunes, etc.), citrus fruits (Satsuma mandarins, oranges, lemons, limes, grapefruits, etc.), nuts (chestnuts, walnuts, hazelnuts, almonds, pistachios, cashews, macadamia nuts, etc.), berries (blueberries, cranberries, blackberries, raspberries, etc.), grapes, persimmons, figs, olives, loquats, bananas, coffee, dates, coconut palms, ornamental plants, forest plants, lawn grasses,Grass. ,

[0072] The above-mentioned plants are not particularly limited as long as they are varieties that are commonly cultivated, and include plants that can be produced by natural crossbreeding, plants that can be generated by mutation, F1 hybrid plants, and genetically modified crops. Examples of genetically modified crops include plants that have been conferred resistance to herbicides such as HPPD (4-hydroxyphenylpyruvate dioxygenase enzyme) inhibitors such as isoxaflutole, ALS (acetolactate synthase) inhibitors such as imazethapyr and thifensulfuron methyl, EPSP (5-enolpyruvylshikimate-3-phosphate synthase) inhibitors, glutamine synthetase inhibitors, PPO (protoporphyrinogen oxidase) inhibitors, bromoxynil, or dicamba; plants that are capable of synthesizing selective toxins known to be found in the genus Bacillus, such as Bacillus thuringiensis; and plants that can be conferred specific insecticidal activity by synthesizing gene fragments that partially match endogenous genes derived from harmful insects and inducing gene silencing (RNAi; RNA interference) in the target harmful insect.

[0073] The present invention will be explained in more detail below with reference to production examples, formulation examples and test examples, but the present invention is not limited to these examples. In this specification, Me represents a methyl group, Et represents an ethyl group, Pr represents a propyl group, i-Pr represents an isopropyl group, t-Bu represents a tert-butyl group, c-Pr represents a cyclopropyl group, c-Bu represents a cyclobutyl group, c-Pen represents a cyclopentyl group, c-Hex represents a cyclohexyl group, CF3 represents a trifluoromethyl group, OCF3 represents a trifluoromethoxy group, OEt represents an ethoxy group, OPr represents a propoxy group, O(i-Pr) represents an isopropoxy group, Ph represents a phenyl group, Py2 represents a 2-pyridyl group, Py3 represents a 3-pyridyl group, Py4 represents a 4-pyridyl group, and Bn represents a benzyl group. When c-Pr, c-Bu, c-Pen, c-Hex, Ph, Py2, Py3, and Py4 have a substituent, the substituent is written before the symbol along with the position of the substituent. For example, 1-CN-c-Pr represents a 1-cyanocyclopropyl group, 3,4-F2-Ph represents a 3,4-difluorophenyl group, 4-CF3-Py2 represents a 4-(trifluoromethyl)-2-pyridyl group, and 5-OCH2CF2CF3-Py2 represents a 5-(2,2,3,3,3-pentafluoropropoxy)-2-pyridyl group.

[0074] First, examples of the preparation of the present compounds (including the compounds of the present invention) will be shown.

[0075] When the physical properties of a compound are measured by liquid chromatography / mass spectrometry (hereinafter referred to as LCMS), the measured molecular ion value [M+H] + or [M-H] - and retention time (hereinafter referred to as RT). The conditions for liquid chromatography (hereinafter referred to as LC) are as follows:

[0076] [LC conditions] Column: L-column2 ODS, inner diameter 4.6 mm, length 30 mm, particle size 3 μm (Chemicals Evaluation and Research Institute, Japan) UV measurement wavelength: 254 nm Mobile phase: Solution A: 0.1% formic acid aqueous solution, Solution B: 0.1% formic acid acetonitrile Flow rate: 2.0 mL / min Pump: Two LC-20AD pumps (Shimadzu Corporation) (high-pressure gradient) Gradient conditions: Solution is delivered at the concentration gradient shown in [Table LC1].

[0077]

[0078] [MS conditions] Detector: LCMS-2020 (Shimadzu Corporation) Ionization method: DUIS

[0079] Preparation Example 1: To a mixture of 0.20 g of 3-chloro-N'-hydroxypyridine-4-carboxyimidamide (prepared by the method described in JP 2002-114783 A) and 5 mL of DMF, 0.18 g of benzoyl chloride was added under ice-cooling, followed by dropwise addition of 0.13 g of triethylamine under ice-cooling, and the mixture was stirred at 140°C for 6 hours. After cooling to room temperature, saturated aqueous sodium bicarbonate solution was added to the resulting mixture, which was then extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:hexane=30:70) to obtain 0.31 g of Compound 1, which is represented by the following formula: This compound 1: 1 H-NMR (CDCl3) δ: 8.81 (1H, s), 8.67 (1H, d), 8.22 (2H, d), 8.01 (1H, d), 7.65-7.55 (3H, m).

[0080] Preparation Example 1-1 The compound prepared in accordance with Preparation Example 1 and its physical properties are shown below. Formula (B-1) In the compound represented by the formula 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 The combination of the compounds is any of the combinations described in [Table B-1] and [Table B-2].

[0081]

[0082] This compound 2: 1 H-NMR (CDCl3) δ: 8.82 (1H, s), 8.67 (1H, d), 8.28-8.22 (2H, m), 7.99 (1H, d), 7.30-7.24 (2H, m). Compound 3: 1 H-NMR (CDCl3) δ: 8.83 (1H, s), 8.68 (1H, d), 8.24-8.18 (1H, m), 8.01 (1H, d), 7.13-7.07 (2H, m), 2.80 (3H, s). Compound 4: 1 H-NMR (CDCl3) δ: 8.67 (2H, s), 8.21 (2H, dd), 7.64-7.54 (3H, m). Compound 5: 1 H-NMR (CDCl3) δ: 8.60 (2H, s), 8.10 (1H, dd), 7.55-7.35 (3H, m). Compound 6: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.21 (1H, s), 8.11 (1H, d), 7.62 (1H, d), 7.53 (1H, t) Compound 7: 1 H-NMR (CDCl3) δ: 8.68 (2H, s), 8.16 (2H, d), 7.57 (2H, d). Compound 8: 1 H-NMR (CDCl3) δ: 8.59 (2H, s), 8.09 (1H, d), 7.42 (1H, t), 7.29 (2H, d), 2.68 (3H, s). Compound 9: 1 H-NMR (CDCl3) δ: 8.68 (2H, s), 8.04 (1H, br s), 8.04-8.00 (1H, m), 7.46 (2H, d), 2.47 (3H, s). Compound 10: 1 H-NMR (CDCl3) δ: 8.68 (2H, s), 8.10 (2H, d), 7.38 (2H, d), 2.47 (3H, s). This compound 11: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 8.26-8.23 (2H, m), 7.31-7.24 (2H, m). Compound 12: 1 H-NMR (CDCl3) δ: 8.60 (2H, s), 8.08 (1H, d), 7.57 (1H, s), 7.39 (1H, d). Compound 13: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.14 (1H, d), 7.40 (1H, s), 7.38 (1H, d), 2.75 (3H, s). Compound 14: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.32 (1H, s), 8.05 (1H, d), 7.68 (1H, d). Compound 15: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.11 (2H, s), 7.64 (1H, s). Compound 16: 1 H-NMR (CDCl3) δ: 8.70 (2H, s), 8.52 (1H, br s), 8.45 (1H, dd), 7.94 (1H, dd), 7.75 (1H, t). Compound 17: 1 H-NMR (CDCl3) δ: 9.08 (1H, br s), 8.70 (2H, s), 8.55 (2H, dt), 7.85 (1H, dt). Compound 18: 1 H-NMR (CDCl3) δ: 8.59 (2H, s), 7.72 (1H, dd), 7.61 (1H, t), 7.38 (1H, t), 7.08 (1H, dd), 3.81 (3H, s). Compound 19 of the present invention: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.09-8.01 (2H, m), 7.45-7.36 (1H, m). Compound 20 of the present invention: 1 H-NMR (CDCl3) δ: 8.72 (2H, s), 7.79-7.78 (2H, m), 7.15-7.13 (1H, m). This compound 21: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.51 (1H, br s), 8.42 (1H, d), 7.92 (1H, d), 7.76 (1H, t). Compound 22 of the present invention: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.17 (1H, d), 8.08 (1H, s), 7.66-7.64 (1H, m), 7.51 (1H, d). Compound 23 of the present invention: 1 H-NMR (CDCl3) δ: 8.96 (2H, s), 8.17-8.15 (1H, m), 8.04 (1H, s), 7.93 (1H, d). Compound 36 of the present invention: 1 H-NMR (CDCl3) δ: 8.84 (1H, s), 8.70 (1H, d), 8.19 (1H, d), 8.10 (1H, s), 8.01 (1H, d), 7.66 (1H, t), 7.52 (1H, d). Compound 37: 1 H-NMR (CDCl3) δ: 8.84 (1H, s), 8.70 (1H, d), 8.54 (1H, s), 8.36 (1H, d), 8.02 (1H, d), 7.95 (1H, d), 7.69 (1H, t). Compound 38: 1 H-NMR (CDCl3) δ: 8.85 (1H, s), 8.71 (1H, d), 8.25-8.23 (1H, m), 8.13 (1H, d), 8.04-8.01 (1H, m), 7.66-7.62 (1H, m), 7.57-7.52 (1H, m). Compound 39 of the present invention: 1 H-NMR (CDCl3) δ: 8.85 (1H, s), 8.71 (1H, d), 8.06-8.05 (1H, m), 8.00 (1H, d), 7.87-7.83 (1H, m), 7.41-7.38 (1H, m). This compound 40: 1 H-NMR (CDCl3) δ: 8.70 (2H, s), 8.40-8.39 (1H, m), 8.17 (1H, d), 7.80 (1H, d), 7.48 (1H, t). Compound 41: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.60-8.58 (1H, m), 8.22-8.18 (1H, m), 8.01-7.98 (1H, m), 7.34 (1H, t). Compound 42: 1 H-NMR (CDCl3) δ: 8.68 (2H, s), 8.24 (1H, s), 8.04 (1H, d), 7.69 (1H, d), 7.52 (1H, t), 1.40 (9H, s). Compound 43 of the present invention: 1 H-NMR (CDCl3) δ: 8.70 (2H, s), 8.10 (1H, d), 8.00-7.98 (1H, m), 7.61 (1H, t), 7.46-7.43 (1H, m), 6.63 (1H, t). Compound 44: 1 H-NMR (CDCl3) δ: 8.68 (2H, s), 7.85 (2H, s), 7.29 (1H, s), 2.43 (6H, s). Compound 45: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.34-8.30 (1H, m), 8.16-8.11 (1H, m), 7.37 (1H, t). Compound 46 of the present invention: 1 H-NMR (CDCl3) δ: 8.70 (2H, s), 8.06-8.04 (1H, m), 7.84 (1H, d), 7.40 (1H, d). Compound 47: 1 H-NMR (CDCl3) δ: 8.69 (2H, s), 8.49-8.46 (1H, m), 8.20-8.16 (1H, m), 7.34 (1H, t). Compound 48 of the present invention: 1 H-NMR (CDCl3) δ: 8.70 (2H, s), 8.20-8.19 (1H, m), 7.90-7.86 (1H, m), 7.57-7.53 (1H, m). Compound 49: 1 H-NMR (CDCl3) δ: 8.84 (2H, s), 8.52 (1H, s), 8.43 (1H, d), 7.93 (1H, d), 7.76 (1H, t). Compound 56 of the present invention: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.06-8.02 (1H, m), 7.96-7.91 (1H, m), 7.61-7.55 (1H, m), 7.40-7.34 (1H, m).

[0083] Preparation Example 2: To a mixture of 0.40 g of 3,5-dichloro-N-hydroxyisonicotinimidoyl chloride, prepared by the method described in WO 2002 / 081482, and 20 mL of tetrahydrofuran, 0.24 mL of 4-ethynyl-1,2-difluorobenzene was added under ice-cooling, and then 0.55 mL of triethylamine was added dropwise under ice-cooling, followed by stirring at room temperature for 20 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:hexane=25:75) to obtain 0.30 g of Compound 24, which is represented by the following formula: This compound 24: 1 H-NMR (CDCl3) δ: 8.66 (2H, s), 7.73-7.57 (2H, m), 7.37-7.28 (1H, m), 6.65 (1H, s).

[0084] Production Example 3: To a mixture of 0.73 g of 3,5-dichloropyridine-4-carboxylic acid and 10 mL of toluene, 0.33 mL of thionyl chloride was added at room temperature, followed by stirring under reflux for 3 hours. After cooling to room temperature, the toluene was distilled off, and 5 mL of DMF and 0.72 g of 3,4-difluorobenzohydrazide were added to the resulting residue, followed by stirring under reflux for 8 hours. 50 mL of saturated aqueous sodium bicarbonate solution was added to the resulting mixture, followed by extraction with ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:hexane=1:1) to yield 0.21 g of 3,5-dichloro-N'-(3,4-difluorobenzoyl)pyridine-4-carbohydrazide. To a mixture of 0.21 g of the obtained 3,5-dichloro-N'-(3,4-difluorobenzoyl)pyridine-4-carbohydrazide and 5 mL of acetonitrile, 0.17 g of paratoluenesulfonyl chloride and 0.35 mL of triethylamine were added sequentially at room temperature, and the mixture was stirred at room temperature for 3 hours. A saturated aqueous solution of sodium bicarbonate was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane = 1:10) to obtain 0.11 g of the present compound 25 represented by the following formula. This compound 25: 1 H-NMR (CDCl3) δ: 8.77 (2H, s), 8.04-7.95 (2H, m), 7.44-7.38 (1H, m).

[0085] Preparation Example 4: To a mixture of 0.53 g of 3-methoxypyridine-4-carboxylic acid and 15 mL of toluene, 0.3 mL of thionyl chloride and 0.1 mL of DMF were added at room temperature, followed by stirring under reflux for 3 hours. After cooling to room temperature, the toluene was distilled off, and 5 mL of THF was added to the resulting residue. To the resulting mixture, a mixture of 0.4 g of 3,4-difluorobenzenecarboximidamide and 10 mL of THF, and 0.86 mL of diazabicycloundecene were added sequentially at room temperature, followed by stirring at room temperature for 3 hours. A saturated aqueous solution of sodium bicarbonate was added to the resulting mixture, followed by extraction with ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:hexane = 1:10) to obtain 0.24 g of Compound 26, represented by the following formula: This compound 26: 1 H-NMR (CDCl3) δ: 8.65 (1H, s), 8.51 (1H, d), 8.08-7.99 (3H, m), 7.39-7.30 (1H, m), 4.18 (3H, s).

[0086] Preparation Example 5: A mixture of 900 mg of 3-(3,4-difluorophenyl)-1H-pyrazole prepared by the method described in WO 2020 / 043866, 910 mg of 3,4,5-trichloropyridine, 1.0 g of potassium carbonate, and 10 mL of DMF was stirred at 50°C for 8 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:hexane = 30:70) to obtain 1.0 g of compound 27 of the present invention represented by the following formula. Compound 27 of the present invention: 1 H-NMR (CDCl3) δ: 8.70 (2H, s), 7.71-7.69 (2H, m), 7.59-7.58 (1H, m), 7.23-7.20 (1H, m), 6.80 (1H, d).

[0087] Preparation Example 6: A mixture of 2.2 g of 3,5-dichloropyridine-4-carbohydrazide prepared by the method described in WO 2012 / 098416, 1.38 g of 4-chlorobenzonitrile, 1.38 g of potassium carbonate, and 20 mL of 1-butanol was stirred at 140°C for 6 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:hexane=30:70) to obtain 390 mg of Compound 28 represented by the following formula: Compound 28: LCMS: 325 [M+H] + , RT = 1.94 minutes

[0088] Preparation Example 6-1 Compounds prepared according to Preparation Example 6 and their physical properties are shown below. This compound 33: 1 H-NMR (CDCl3) δ: 8.68 (2H, s), 8.38 (1H, s), 8.28 (1H, d), 7.76 (1H, d), 7.68-7.63 (1H, m).

[0089] This compound 34: 1 H-NMR (CDCl3) δ: 8.68 (2H, s), 7.83-7.79 (2H, m), 7.10-7.05 (1H, m).

[0090] Preparation Example 7: A mixture of 390 mg of compound 28, 94 μL of methyl iodide, 492 mg of cesium carbonate, and 5 mL of DMF was stirred at room temperature for 6 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography (ethyl acetate:hexane=30:70) to obtain 50 mg of compound 29 represented by the following formula: Compound 29: 8.62 (2H, s), 7.73 (2H, d), 7.53 (2H, d), 4.12 (3H, s).

[0091] Production Example 8 Compounds produced according to Production Example 7 and their physical properties are shown below. This compound 30:1 H-NMR (CDCl3) δ: 8.63 (2H, s), 7.74 (1H, d), 7.65-7.60 (2H, m), 7.41 (1H, d), 4.15 (3H, s).

[0092] Compound 31 of the present invention: 1 H-NMR (CDCl3) δ: 8.72 (2H, s), 7.85-7.80 (2H, m), 7.04-7.00 (1H, m), 3.83 (3H, s).

[0093] This compound 32: 1 H-NMR (CDCl3) δ: 8.63 (2H, s), 8.05-8.03 (1H, m), 7.86 (1H, m), 7.73(1H, s), 4.16 (3H, s).

[0094] This compound 35: 1 H-NMR (CDCl3) δ: 8.72 (2H, s), 8.43 (1H, s), 8.33 (1H, d), 7.70-7.67 (1H, m), 7.61-7.57 (1H, m), 3.83 (3H, s).

[0095] Preparation Example 9: A mixture of 160 mg of Compound 49, 65.8 mg of methylboronic acid, 52.7 mg of [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II), 469 mg of cesium carbonate, and 2 mL of DME was stirred at 80°C for 4 hours under a nitrogen atmosphere. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography to obtain 30 mg of Compound 50, which is represented by the following formula: This compound 50: 1 H-NMR (CDCl3) δ: 8.76 (1H, s), 8.54 (1H, s), 8.51 (1H, s), 8.42 (1H, d), 7.93-7.91 (1H, m), 7.78-7.73 (1H, m), 2.32 (3H, s).

[0096] Production Example 10 Compounds produced according to Production Example 9 and their physical properties are shown below. Compound 51 of the present invention: 1 H-NMR (CDCl3) δ: 8.72 (1H, s), 8.51 (1H, s), 8.43 (1H, d), 8.33 (1H, s), 7.93-7.90 (1H, m), 7.75 (1H, t), 1.87-1.79 (1H, m), 0.95-0.90 (2H, m), 0.82-0.78 (2H, m).

[0097] Compound 52 of the present invention: 1 H-NMR (CDCl3) δ: 8.52 (1H, s), 8.43 (1H, d), 8.25 (2H, s), 7.92-7.90 (1H, m), 7.75 (1H, t), 1.88-1.81 (2H, m), 0.90-0.83 (4H, m), 0.77-0.73 (4H, m).

[0098] Preparation Example 11: To a mixture of 0.2 g of sodium hydride (oil, 60%), 180 mg of the present compound 21, and 2 mL of THF, 1 mL of methanol was added and stirred at 80°C for 4 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel column chromatography to obtain 90 mg of the present compound 53 represented by the following formula. Compound 53 of the present invention: 1 H-NMR (CDCl3) δ: 8.50 (1H, s), 8.45 (1H, s), 8.41 (1H, d), 8.38 (1H, s), 7.90 (1H, d), 7.73 (1H, t), 3.96 (3H, s).

[0099] Preparation Example 11-1 The compound prepared in accordance with Preparation Example 11 and its physical properties are shown below. Formula (C-1) In the compound represented by the formula 1 , R 2 , R 3 , R 4 , R 5 , R6 and R 7 The combination is any of the combinations described in [Table C-1] and [Table C-2].

[0100]

[0101] Compound 54 of the present invention: 1 H-NMR (CDCl3) δ: 8.50 (1H, s), 8.41 (2H, d), 8.36 (1H, s), 7.90 (1H, d), 7.73 (1H, t), 4.22 (2H, q), 1.36 (3H, t). Compound 55 of the present invention: 1 H-NMR (CDCl3) δ: 8.50 (1H, s), 8.43-8.32 (3H, m), 7.89 (1H, d), 7.73 (1H, t), 4.74-4.68 (1H, m), 1.32 (6H, d). Compound 57 of the present invention: 1 H-NMR (CDCl3) δ: 8.45 (1H, s), 8.38 (1H, s), 8.04-8.01 (1H, m), 7.95-7.91 (1H, m), 7.60-7.53 (1H, m), 7.38-7.33 (1H, m), 3.96 (3H, s). Compound 58 of the present invention: 1 H-NMR (CDCl3) δ: 8.42 (1H, s), 8.35 (1H, s), 8.04-8.01 (1H, m), 7.94-7.90 (1H, m), 7.60-7.53 (1H, m), 7.38-7.32 (1H, m), 4.22 (2H, q), 1.36 (3H, t). Compound 59 of the present invention: 1 H-NMR (CDCl3) δ: 8.57 (1H, s), 8.53 (1H, s), 8.05-8.01 (1H, m), 7.95-7.91 (1H, m), 7.60-7.54 (1H, m), 7.38-7.33 (1H, m), 2.55 (3H, s). Compound 60 of the present invention: 1H-NMR (CDCl3) δ: 8.45 (1H, s), 8.38 (1H, s), 8.24-8.22 (1H, m), 8.13-8.09 (1H, m), 7.64-7.60 (1H, m), 7.52 (1H, t), 3.95 (3H, s). Compound 61 of the present invention: 1 H-NMR (CDCl3) δ: 8.39 (1H, s), 8.37 (1H, s), 8.24-8.21 (1H, m), 8.13-8.10 (1H, m), 7.64-7.60 (1H, m), 7.53 (1H, t), 4.73-4.67 (1H, m), 1.33 (6H, d). Compound 62 of the present invention: 1 H-NMR (CDCl3) δ: 8.44 (1H, s), 8.36 (1H, s), 8.05 (1H, s), 8.03-8.00 (1H, m), 7.46-7.44 (2H, m), 3.95 (3H, s), 2.46 (3H, s). Compound 63 of the present invention: 1 H-NMR (CDCl3) δ: 8.41 (1H, s), 8.34 (1H, s), 8.05 (1H, s), 8.03-8.01 (1H, m), 7.46-7.44 (2H, m), 4.21 (2H, q), 2.46 (3H, s), 1.35 (3H, t). Compound 64 of the present invention: 1 H-NMR (CDCl3) δ: 8.43 (1H, s), 8.35 (1H, s), 7.84-7.82 (2H, m), 7.26-7.24 (1H, m), 3.93 (3H, s), 2.41 (6H, s). Compound 65 of the present invention: 1 H-NMR (CDCl3) δ: 8.42 (1H, s), 8.35 (1H, s), 8.19-8.16 (1H, m), 8.08 (1H, s), 7.63 (1H, t), 7.52-7.48 (1H, m), 4.22 (2H, q), 1.36 (3H, t). Compound 66 of the present invention: 1H-NMR (CDCl3) δ: 8.69-8.66 (2H, m), 8.42-8.40 (1H, m), 8.14-8.09 (1H, m), 7.04-7.00 (1H, m), 4.22 (2H, q), 1.54 (3H, t). Compound 67: 1 H-NMR (CDCl3) δ: 8.42-8.41 (1H, m), 8.40 (1H, s), 8.33 (1H, s), 8.13-8.09 (1H, m), 7.01 (1H, d), 4.26-4.17 (4H, m), 1.53 (3H, t), 1.35 (3H, t). Compound 68: 1 H-NMR (CDCl3) δ: 8.39 (1H, s), 8.36 (1H, s), 7.53-7.51 (1H, m), 7.50-7.46 (1H, m), 6.87-6.83 (1H, m), 4.73-4.61 (2H, m), 1.39 (6H, d), 1.33 (6H, d). Compound 69 of the present invention: 1 H-NMR (CDCl3) δ: 8.58 (1H, s), 8.54 (1H, s), 8.52-8.50 (1H, m), 8.44-8.41 (1H, m), 7.93-7.90 (1H, m), 7.77-7.72 (1H, m), 2.56 (3H, s). Compound 70 of the present invention: 1 H-NMR (CDCl3) δ: 8.57 (1H, s), 8.53 (1H, s), 8.25-8.23 (1H, m), 8.14-8.10 (1H, m), 7.64-7.61 (1H, m), 7.53 (1H, t), 2.55 (3H, s). Compound 71 of the present invention: 1 H-NMR (CDCl3) δ: 8.45 (2H, s), 8.23 ​​(1H, s), 8.15-8.09 (1H, m), 7.65-7.58 (1H, m), 7.56-7.49 (1H, m), 2.52 (6H, s). Compound 77 of the present invention: 1H-NMR (CDCl3) δ: 8.56 (1H, s), 8.53 (1H, s), 7.78-7.74 (2H, m), 7.13-7.07 (1H, m), 2.54 (3H, s). Compound 78 of the present invention: 1 H-NMR (CDCl3) δ: 8.55 (1H, s), 8.50 (1H, s), 7.84 (2H, s), 7.26 (1H, s), 2.53 (3H, s), 2.41 (6H, s).

[0102] Preparation Example 12: A mixture of 160 mg of the present invention compound 69, 2 mL of chloroform, and 212 mg of metachloroperbenzoic acid was stirred at room temperature for 2 hours. The resulting mixture was washed successively with aqueous sodium thiosulfate and aqueous sodium bicarbonate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel chromatography to obtain 150 mg of the present invention compound 72 represented by the following formula. Compound 72 of the present invention: 1 H-NMR (CDCl3) δ: 9.30 (1H, s), 9.07 (1H, s), 8.48 (1H, s), 8.41 (1H, d), 7.92 (1H, d), 7.75 (1H, t), 3.36 (3H, s).

[0103] Preparation Example 13: A mixture of 360 mg of Compound 21, 4 mL of chloroform, and 247 mg of metachloroperbenzoic acid was stirred at 70°C for 2 hours. The resulting mixture was washed successively with aqueous sodium thiosulfate and aqueous sodium bicarbonate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel chromatography to obtain 250 mg of Compound 73, which is represented by the following formula: This compound 73: 1 H-NMR (CDCl3) δ: 8.49 (1H, s), 8.41 (1H, d), 8.32 (2H, s), 7.93 (1H, d), 7.75 (1H, t).

[0104] Preparation Example 14: A mixture of 50 mg of the present invention compound 69, 2 mL of chloroform, and 33 mg of metachloroperbenzoic acid was stirred at 0°C for 1 hour. The resulting mixture was washed successively with aqueous sodium thiosulfate and aqueous sodium bicarbonate. The resulting organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was subjected to silica gel chromatography to obtain 40 mg of the present invention compound 74 represented by the following formula. Compound 74 of the present invention: 1 H-NMR (CDCl3) δ: 9.32 (1H, s), 8.96 (1H, s), 8.47 (1H, s), 8.41 (1H, d), 7.95 (1H, d), 7.78 (1H, t), 3.07 (3H, s).

[0105] Production Example 15 Compounds produced according to Production Example 14 and their physical properties are shown below. Compound 75 of the present invention: 1 H-NMR (CDCl3) δ: 9.32 (1H, s), 8.96 (1H, s), 8.03-8.00 (1H, m), 7.92-7.88 (1H, m), 7.64-7.58 (1H, m), 7.43-7.38 (1H, m), 3.08 (3H, s).

[0106] Compound 76 of the present invention: 1 H-NMR (CDCl3) δ: 9.32 (1H, s), 8.96 (1H, s), 8.20-8.18 (1H, m), 8.12-8.08 (1H, m), 7.68-7.65 (1H, m), 7.58-7.54 (1H, m), 3.07 (3H, s).

[0107] Next, examples of the present compounds and compounds of the present invention produced according to any of the production examples described in the Examples and the production methods described in this specification are shown below.

[0108] Formula (L-1) In the compound represented by the formula (hereinafter referred to as compound (L-1)), R 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 , R5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX1).

[0109]

[0110] In compound (L-1), R 1 and R 2 is a fluorine atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX2). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX3). 1 and R 2 is a chlorine atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX4). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX5). 1 and R 2 is a bromine atom, and R 4 , R 5 , R 6 , and R7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX6). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX7). 1 and R 2 is an iodine atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX8). 1 is a methyl group, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX9). 1 and R 2 is a methyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX10). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX11). 1 and R 2 is an ethyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX12). 1 is a propyl group, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX13). 1 and R 2 is a propyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX14). 1 is an isopropyl group, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX15). 1 and R 2 is an isopropyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX16). 1 is a cyclopropyl group, and R2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX17). 1 and R 2 is a cyclopropyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX18). 1 is CF3, and R 2 is a hydrogen atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX19). 1 and R 2 is CF3, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX20).

[0111] In the compound (L-1), R 1 is a chlorine atom, and R 2 is a bromine atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX21). 1 is a chlorine atom, and R 2 is an iodine atom, and R 4 , R 5 , R6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX22). 1 is a chlorine atom, and R 2 is a methyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX23). 1 is a chlorine atom, and R 2 is an ethyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX24). 1 is a chlorine atom, and R 2 is a propyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX25). 1 is a chlorine atom, and R 2 is an isopropyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX26). 1 is a chlorine atom, and R 2 is a cyclopropyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX27). 1 is a chlorine atom, and R 2 is CF3, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX28). 1 is a bromine atom, and R 2 is an iodine atom, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX29). 1 is a bromine atom, and R 2 is a methyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX30). 1 is a bromine atom, and R 2 is an ethyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX31). 1 is a bromine atom, and R 2 is a propyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX32). 1is a bromine atom, and R 2 is an isopropyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX33). 1 is a bromine atom, and R 2 is a cyclopropyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX34). 1 is a bromine atom, and R 2 is CF3, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX35). 1 is a methyl group, and R 2 is an ethyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX36). 1 is a methyl group, and R 2 is a propyl group, and R 4 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX37). 1 is an ethyl group, and R 2 is a propyl group, and R 4 , R 5 , R6 , and R 7 is a hydrogen atom, and R 3 is any one of the substituents described in [Table L1] (hereinafter referred to as compound group SX38).

[0112] In compound (L-1), R 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX39). 1 and R 2 is a fluorine atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX40). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX41). 1 and R 2 is a chlorine atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX42). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6, and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX43). 1 and R 2 is a bromine atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX44). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX45). 1 and R 2 is an iodine atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX46). 1 is a methyl group, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX47). 1 and R 2 is a methyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX48). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX49). 1 and R 2 is an ethyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX50). 1 is a propyl group, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX51). 1 and R 2 is a propyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX52). 1 is an isopropyl group, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX53). 1 and R 2 is an isopropyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX54). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX55). 1 and R 2 is a cyclopropyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX56). 1 is CF3, and R 2 is a hydrogen atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX57). 1 and R 2 is CF3, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4is any of the substituents described in any of [Table L1] to [Table L3] (hereinafter referred to as compound group SX58).

[0113] In compound (L-1), R 1 is a chlorine atom, and R 2 is a bromine atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX59). 1 is a chlorine atom, and R 2 is an iodine atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX60). 1 is a chlorine atom, and R 2 is a methyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX61). 1 is a chlorine atom, and R 2 is an ethyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX62). 1 is a chlorine atom, and R 2 is a propyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX63). 1 is a chlorine atom, and R 2 is an isopropyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX64). 1 is a chlorine atom, and R 2 is a cyclopropyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX65). 1 is a chlorine atom, and R 2 is CF3, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX66). 1 is a bromine atom, and R 2 is an iodine atom, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX67). 1 is a bromine atom, and R 2 is a methyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX68). 1 is a bromine atom, and R 2 is an ethyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX69). 1 is a bromine atom, and R 2 is a propyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX70). 1 is a bromine atom, and R 2 is an isopropyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX71). 1 is a bromine atom, and R 2 is a cyclopropyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX72). 1 is a bromine atom, and R 2 is CF3, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX73). 1 is a methyl group, and R 2 is an ethyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX74). 1 is a methyl group, and R 2 is a propyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX75). 1 is an ethyl group, and R 2 is a propyl group, and R 3 , R 5 , R 6 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to L3] (hereinafter referred to as compound group SX76).

[0114] In compound (L-1), R 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX77). 1 and R 2 is a fluorine atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX78). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX79). 1 and R 2 is a chlorine atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX80). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX81). 1 and R 2 is a bromine atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX82). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX83). 1 and R 2 is an iodine atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX84). 1 is a methyl group, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX85). 1 and R 2 is a methyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX86). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX87). 1 and R 2 is an ethyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX88). 1 is a propyl group, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX89). 1 and R 2 is a propyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX90). 1 is an isopropyl group, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX91). 1 and R 2 is an isopropyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX92). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX93). 1 and R 2 is a cyclopropyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX94). 1 is CF3, and R 2 is a hydrogen atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX95). 1 and R 2 is CF3, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any of the substituents described in any of [Table L1] to [Table L2] (hereinafter referred to as compound group SX96).

[0115] In compound (L-1), R 1 is a chlorine atom, and R 2 is a bromine atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX97). 1 is a chlorine atom, and R 2 is an iodine atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX98). 1 is a chlorine atom, and R 2 is a methyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX99). 1 is a chlorine atom, and R 2 is an ethyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX100). 1 is a chlorine atom, and R 2 is a propyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX101). 1 is a chlorine atom, and R 2 is an isopropyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX102). 1 is a chlorine atom, and R 2 is a cyclopropyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX103). 1 is a chlorine atom, and R 2 is CF3, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX104). 1 is a bromine atom, and R 2 is an iodine atom, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX105). 1 is a bromine atom, and R 2 is a methyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX106). 1 is a bromine atom, and R 2 is an ethyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX107). 1 is a bromine atom, and R 2 is a propyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX108). 1 is a bromine atom, and R 2 is an isopropyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX109). 1 is a bromine atom, and R 2 is a cyclopropyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX110). 1 is a bromine atom, and R 2 is CF3, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX111). 1 is a methyl group, and R 2 is an ethyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX112). 1 is a methyl group, and R 2 is a propyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX113). 1 is an ethyl group, and R 2 is a propyl group, and R 3 , R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any of the substituents described in any of [Table L1] to [Table L2] (hereinafter referred to as compound group SX114).

[0116] In compound (L-1), R 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is a fluorine atom, and R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX115). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is a chlorine atom, and R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX116). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is a bromine atom, and R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX117). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is an iodine atom, and R 4, R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX118). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is a methyl group, and R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX119). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is a methoxy group, and R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX120). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is CF3, and R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX121). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 3 is OCF3, and R 4 , R 6 , and R 7 is a hydrogen atom, and R 5 is any one of the substituents described in any one of [Table L1] and [Table L2] (hereinafter referred to as compound group SX122). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX123). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX124). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX125). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX126). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX127). 1is a fluorine atom, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX128). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX129). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX130). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX131). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX132). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX133). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX134). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX135). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX136). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is CF3, and R 3 , R 5 , and R7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX137). 1 is a fluorine atom, and R 2 is a hydrogen atom, and R 4 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any of the substituents described in any of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX138).

[0117] In compound (L-1), R 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX139). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX140). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX141). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX142). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX143). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX144). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX145). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX146). 1is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX147). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX148). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX149). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX150). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX151). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX152). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX153). 1 is a chlorine atom, and R 2 is a hydrogen atom, and R 4 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 6 is any of the substituents described in any of [Table L1] to [Table L3] (hereinafter referred to as compound group SX154).

[0118] In compound (L-1), R 1 is a bromine atom, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX155). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3, R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX156). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX157). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX158). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX159). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX160). 1 is a bromine atom, and R 2 is a hydrogen atom, and R5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX161). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX162). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX163). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX164). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX165). 1is a bromine atom, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX166). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX167). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX168). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX169). 1 is a bromine atom, and R 2 is a hydrogen atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4is any of the substituents described in any of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX170).

[0119] In compound (L-1), R 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX171). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX172). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX173). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX174). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX175). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX176). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX177). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX178). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX179). 1 is an iodine atom, and R 2is a hydrogen atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX180). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX181). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX182). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX183). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX184).1 is an iodine atom, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX185). 1 is an iodine atom, and R 2 is a hydrogen atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX186).

[0120] In compound (L-1), R 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX187). 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX188). 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX189). 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX190). 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX191). 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX192). 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX193). 1 is a methyl group, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX194). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX195). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX196). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX197). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX198). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX199). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX200). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX201). 1 is a methyl group, and R 2 is a hydrogen atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to L3] (hereinafter referred to as compound group SX202).

[0121] In compound (L-1), R 1 is an ethyl group, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX203). 1is an ethyl group, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX204). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX205). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX206). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX207). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX208). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX209). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX210). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX211). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX212). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX213). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX214). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX215). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX216). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX217). 1 is an ethyl group, and R 2 is a hydrogen atom, and R 6 is OCF3, and R3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to L3] (hereinafter referred to as compound group SX218).

[0122] In compound (L-1), R 1 is CF3, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX219). 1 is CF3, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX220). 1 is CF3, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX221). 1 is CF3, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX222). 1is CF3, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX223). 1 is CF3, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX224). 1 is CF3, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX225). 1 is CF3, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX226). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX227). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX228). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX229). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX230). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX231). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R 3 , R 5 , and R7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX232). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX233). 1 is CF3, and R 2 is a hydrogen atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to L3] (hereinafter referred to as compound group SX234).

[0123] In compound (L-1), R 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX235). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX236). 1 is a cyclopropyl group, and R 2is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX237). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX238). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX239). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX240). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX241). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX242). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX243). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX244). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX245). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX246). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX247). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX248). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX249). 1 is a cyclopropyl group, and R 2 is a hydrogen atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX250).

[0124] In compound (L-1), R 1is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX251). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX252). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX253). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX254). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX255). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX256). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX257). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX258). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX259). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a chlorine atom, and R3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX260). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX261). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX262). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX263). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX264). 1is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX265). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX266).

[0125] In compound (L-1), R 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C-F and R 3 , R 5 , and R 6 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX267). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C—Cl, and R 3 , R 5 , and R 6 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX268). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C—Br, and R 3 , R 5 , and R 6 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX269). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C-I, and R 3 , R 5 , and R 6 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX270). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C-Me, and R 3 , R 5 , and R 6 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX271). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C-OMe, and R 3 , R 5 , and R 6 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX272). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C-CF3, and R 3 , R 5 , and R 6 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX273). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 7 is C-OCF3, and R3 , R 5 , and R 6 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX274). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX275). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX276). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX277). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX278). 1is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX279). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX280). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX281). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX282). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX283). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX284). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX285). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX286). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX287). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is a methoxy group, and R3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX288). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX289). 1 is a methylsulfanyl group, and R 2 is a hydrogen atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX290).

[0126] In compound (L-1), R 1 and R 2 is a fluorine atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX291). 1 and R 2 is a fluorine atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX292). 1 and R2 is a fluorine atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX293). 1 and R 2 is a fluorine atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX294). 1 and R 2 is a fluorine atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX295). 1 and R 2 is a fluorine atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX296). 1 and R 2 is a fluorine atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX297). 1 and R2 is a fluorine atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX298). 1 and R 2 is a fluorine atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX299). 1 and R 2 is a fluorine atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX300). 1 and R 2 is a fluorine atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX301). 1 and R 2 is a fluorine atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX302). 1 and R2 is a fluorine atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX303). 1 and R 2 is a fluorine atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX304). 1 and R 2 is a fluorine atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX305). 1 and R 2 is a fluorine atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to L3] (hereinafter referred to as compound group SX306).

[0127] In compound (L-1), R 1 and R 2 is a chlorine atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX307). 1 and R 2 is a chlorine atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX308). 1 and R 2 is a chlorine atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX309). 1 and R 2 is a chlorine atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX310). 1 and R 2 is a chlorine atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX311). 1 and R 2 is a chlorine atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX312). 1 and R 2 is a chlorine atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX313). 1 and R 2 is a chlorine atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX314). 1 and R 2 is a chlorine atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX315). 1 and R 2 is a chlorine atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX316). 1 and R 2 is a chlorine atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX317). 1 and R 2 is a chlorine atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX318). 1 and R 2 is a chlorine atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX319). 1 and R 2 is a chlorine atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX320). 1 and R 2 is a chlorine atom, and R 6 is CF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX321). 1 and R 2 is a chlorine atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4is any of the substituents described in any of [Tables L1] to L3] (hereinafter referred to as compound group SX322).

[0128] In compound (L-1), R 1 and R 2 is a bromine atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX323). 1 and R 2 is a bromine atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX324). 1 and R 2 is a bromine atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX325). 1 and R 2 is a bromine atom, and R 5 is an iodine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX326). 1 and R 2 is a bromine atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX327). 1 and R 2 is a bromine atom, and R 5 is a methoxy group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX328). 1 and R 2 is a bromine atom, and R 5 is CF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX329). 1 and R 2 is a bromine atom, and R 5 is OCF3, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to [Table L3] (hereinafter referred to as compound group SX330). 1 and R 2 is a bromine atom, and R 6 is a fluorine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX331). 1 and R 2 is a bromine atom, and R 6 is a chlorine atom, and R 3 , R 5 , and R 7is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX332). 1 and R 2 is a bromine atom, and R 6 is a bromine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX333). 1 and R 2 is a bromine atom, and R 6 is an iodine atom, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX334). 1 and R 2 is a bromine atom, and R 6 is a methyl group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX335). 1 and R 2 is a bromine atom, and R 6 is a methoxy group, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX336). 1 and R 2 is a bromine atom, and R 6 is CF3, and R 3 , R 5 , and R 7is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX337). 1 and R 2 is a bromine atom, and R 6 is OCF3, and R 3 , R 5 , and R 7 is a hydrogen atom, and R 4 is any of the substituents described in any of [Tables L1] to L3] (hereinafter referred to as compound group SX338).

[0129] In compound (L-1), R 1 and R 2 is an iodine atom, and R 5 is a fluorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX339). 1 and R 2 is an iodine atom, and R 5 is a chlorine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L1] to [Table L3] (hereinafter referred to as compound group SX340). 1 and R 2 is an iodine atom, and R 5 is a bromine atom, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX341). 1 and R 2 is an iodine atom, and R 5 is an iodine atom, and R 3 , R6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Tables L1] to L3] (hereinafter referred to as compound group SX342). 1 and R 2 is an iodine atom, and R 5 is a methyl group, and R 3 , R 6 , and R 7 is a hydrogen atom, and R 4 is any one of the substituents described in any one of [Table L...

Claims

1. Formula (I) 【Chemical 1】 〔wherein R 1 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more substituents selected from Group A}, a C3-C7 cycloalkyl group, a C3-C7 cycloalkenyl group, a phenyl group, a 3-7 membered non-aromatic heterocyclic group, or a 5- or 6-membered aromatic heterocyclic group {the C3-C7 cycloalkenyl group, the phenyl group, the 3-7 membered non-aromatic heterocyclic group, and the 5- or 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group C}, a nitro group, NR 8 R 9 、S(O) m R 10 , or a halogen atom, and m represents 0, 1 or 2, R 2 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted with one or more substituents selected from Group A}, a C3-C7 cycloalkyl group, a C3-C7 cycloalkenyl group, a phenyl group, a 3-7 membered non-aromatic heterocyclic group, or a 5- or 6-membered aromatic heterocyclic group {the C3-C7 cycloalkenyl group, the phenyl group, the 3-7 membered non-aromatic heterocyclic group, and the 5- or 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from Group C}, a nitro group, NR 8a R 9a , S(O) n R 10a , a halogen atom, or a hydrogen atom, and n represents 0, 1 or 2, R 3 and R 7 which are the same or different and each represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, R 4 and R 6 are the same or different and represent a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C3-C6 cycloalkyl group, a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, the C3-C6 cycloalkyl group, the phenyl group, and the 5- or 6-membered aromatic heterocyclic group may be substituted with one or more halogen atoms}, a cyano group, a nitro group, a halogen atom, or a hydrogen atom, R 5 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, and the C1-C6 alkylsulfonyl group may be substituted with one or more halogen atoms}, a nitro group, a halogen atom, or a hydrogen atom, R 8 and R 8a are the same or different and each represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or a hydrogen atom, R 9 and R 9a are the same or different and represent a C1-C6 chain hydrocarbon group, a C3-C7 cycloalkyl group, a C3-C7 cycloalkenyl group {the C1-C6 chain hydrocarbon group, the C3-C7 cycloalkyl group and the C3-C7 cycloalkenyl group may be substituted with one or more substituents selected from Group C}, or a hydrogen atom, R 10 and R 10a are the same or different and each represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, Q represents a group represented by formula Q1, a group represented by formula Q2, a group represented by formula Q3, or a group represented by formula Q4 (# represents the bonding site with the pyridine ring, and ● represents the bonding site with the benzene ring), 【Chemical Formula 2】 A 1 represents a nitrogen atom or CR 11 and A 2 represents an oxygen atom, a sulfur atom, or NR 12 , and A 3 represents a nitrogen atom or CR 13 and A 4 represents a nitrogen atom or CR 14 and A 5 represents a nitrogen atom or CR 15 and A 6 represents a nitrogen atom or CR 16 and R 11 、R 13 、R 14 、R 15 and R 16 are the same or different and each represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom. R 12 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or a hydrogen atom. Group A: a group consisting of a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group, a C1-C6 alkylsulfanyl group, a C1-C6 alkylsulfinyl group, a C1-C6 alkylsulfonyl group, a C3-C6 cycloalkyl group {the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkylsulfanyl group, the C1-C6 alkylsulfinyl group, the C1-C6 alkylsulfonyl group, and the C3-C6 cycloalkyl group may be substituted with one or more halogen atoms}, a cyano group, and a halogen atom. Group B: a group consisting of a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C6 alkenyloxy group, a C3-C6 alkynyloxy group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, and the C3-C6 alkynyloxy group may be substituted with one or more halogen atoms}, a hydroxy group, a cyano group, a nitro group, and a halogen atom. Group C: a group consisting of a C1-C6 alkyl group which may be substituted with one or more halogen atoms, a cyano group, and a halogen atom.〕 A method for controlling resistant harmful arthropods, which comprises applying an effective amount of a compound represented by formula (I), or an N-oxide thereof or a salt thereof, to the resistant harmful arthropods or the habitat of the resistant harmful arthropods.

2. In the compound represented by formula (I), or an N-oxide thereof or a salt thereof, Q is a group represented by formula Q1 or a group represented by formula Q4, A 1 and A 3 is a nitrogen atom, A 2 is an oxygen atom or NR 12 and R 1 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, a nitro group, S(O) m R 10 , or a halogen atom, and R 2 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, a nitro group, S(O) n R 10a , a halogen atom, or a hydrogen atom, the method according to claim 1

3. In the compound represented by formula (I), or an N-oxide thereof or a salt thereof, The method according to claim 1, wherein Q is a group represented by formula Q1.

4. In the compound represented by formula (I), or an N-oxide thereof or a salt thereof, Q is a group represented by formula Q2 or a group represented by formula Q3, A 4 is CR 14 and A 5 is a nitrogen atom or CR 15 and A 6 is a nitrogen atom, R 1 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, a nitro group, S(O) m R 10 , or a halogen atom, and R 2 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, a nitro group, S(O) n R 10a , a halogen atom, or a hydrogen atom, the method according to claim 1.

5. In the compound represented by formula (I), or an N-oxide thereof or a salt thereof, The method according to claim 1, wherein Q is a group represented by formula Q2.

6. Formula (II) [Chemical Formula 3] 〔wherein R 21 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, S(O) ｐ R 28 or a halogen atom, and R 22 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, S(O) ｑ R 29 , a halogen atom, or a hydrogen atom, and R 23 , R 25 and R 27 are the same or different and each represents a fluorine atom or a hydrogen atom, R 24 represents a C1-C6 alkoxy group substituted with one or more halogen atoms, or a fluorine atom, R 26 represents a halogen atom or a hydrogen atom, R 28 and R 29 which are the same or different and each represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, p and q each independently represent 0, 1 or 2. A compound represented by the formula, or an N-oxide thereof or a salt thereof. Claim 7 R 21 is a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or is a halogen atom, R 22 is a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, R 23 , R 25 and R 27 are the same or different and are a fluorine atom or a hydrogen atom, R 24 is a C1-C6 alkoxy group substituted with one or more halogen atoms, or a fluorine atom, R 26 The compound according to claim 6, wherein R is a halogen atom or a hydrogen atom, or an N-oxide thereof or a salt thereof. Claim 8 Formula (II-a) 【Chemical Formula 4】 [In the formula, R 21a is a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 alkoxy group and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, or S(O) ｒ R 28a represents, R 22a represents a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 alkoxy group and the C3-C7 cycloalkyl group may be substituted with one or more halogen atoms}, S(O) ｓ R 29a or a halogen atom, and R 23a , R 25a and R 27a are the same or different and each represents a halogen atom or a hydrogen atom, R 24a represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a C1-C6 alkoxy group substituted with one or more halogen atoms, or a halogen atom, R 26a represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, R 28a and R 29a are the same or different and each represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, r and s each independently represent 0, 1 or 2. A compound represented by the formula, or an N-oxide thereof or a salt thereof. Claim 9 Formula (III) 【Chemical Formula 5】 [In the formula, R 31 、R 32 、R 33 、R 34 、R 35 、R 36 、and R 37 's combination is R 31 and R 32 is a chlorine atom, and R 33 R 35 and R 37 is a hydrogen atom, R 34 is a C1-C6 alkoxy group substituted with one or more halogen atoms, R 36 a combination in which R is a halogen atom; or, R 31 is a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms or a bromine atom, R 32 is a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a bromine atom, or a hydrogen atom, R 33 , R 35 and R 37 are the same or different and are a fluorine atom or a hydrogen atom, R 34 is a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be substituted with one or more halogen atoms, or a halogen atom, and R 36 represents a combination in which R is a halogen atom or a hydrogen atom, R 38 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or a hydrogen atom. A compound represented by the formula, or an N-oxide thereof or a salt thereof. Claim 10 Formula (IV) [Chemical Formula 6] [In the formula, R 41 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, or a halogen atom, R 42 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, R 43 , R 45 and R 47 are the same or different and each represents a fluorine atom or a hydrogen atom, R 44 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more halogen atoms, a C1-C6 alkoxy group which may be substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom, R 46 represents a halogen atom or a hydrogen atom. A compound represented by the formula, or an N-oxide thereof or a salt thereof. Claim 11 A composition comprising the compound according to any one of claims 6 to 10, or an N-oxide thereof or a salt thereof, and an inert carrier. Claim 12 A composition comprising one or more components selected from the group consisting of group (a), group (b), group (c) and group (d), and the compound according to any one of claims 6 to 10, or an N-oxide thereof or a salt thereof: Group (a): a group consisting of an insecticidal active ingredient, a acaricidal active ingredient and a nematicidal active ingredient; Group (b): a bactericidal active ingredient; Group (c): a plant growth regulating ingredient; Group (d): a repellent ingredient. Claim 13 A method for controlling resistant harmful arthropods, which comprises applying an effective amount of the compound according to any one of claims 6 to 10, or an N-oxide thereof or a salt thereof, to the resistant harmful arthropods or the habitat of the resistant harmful arthropods. A method for controlling resistant harmful arthropods, which comprises applying an effective amount of the composition according to claim 12 to the resistant harmful arthropods or the habitat of the resistant harmful arthropods. Claim 15 The method according to any one of claims 1 to 5, wherein the resistant harmful arthropod is a hemipteran pest. The method according to claim 14, wherein the resistant harmful arthropod is a hemipteran pest. Claim 17 The method according to any one of claims 1 to 5, wherein the resistant harmful arthropod is a pest of the Aphididae family, the Delphacidae family or the Aleyrodidae family. The method according to claim 14, wherein the resistant harmful arthropod is a pest of the Aphididae family, the Delphacidae family or the Aleyrodidae family. Claim 19 A seed or vegetative reproductive organ retaining an effective amount of the compound according to any one of claims 6 to 10, or an N-oxide thereof or a salt thereof. A seed or vegetative reproductive organ retaining an effective amount of the composition according to claim 12.

Images